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Abstract. 
The self-complementary dodecanucleotide d[CGCQfMeGAATTIGCG) 2 
which contains two 0 6-methyl-2'-deoxyguanosine-.thymine base pairs, has 
been analysed by X-ray diffraction methods and the structure refined to a 
residual error of R=0.185 at 2.OA resolution. The 0 6MedG.T mispair 
Closely resembles a Watson / Crick base pair and there are very few 
structural differences between the 0 6MedG.T duplex and the native 
analogue. The similarity between the 0 6MedG.T base pair and a normal. 
dG.dC base pair explains the failure of mismatch repair enzymes to 
recognise and remove this mutagenic lesion. A series of ultraviolet 
melting studies over a wide pH range on a related dodecamer indicate 
that the 0 6MedG.dC mispair can exist in two conformations, one of which 
is a wobble pair, and the other a protonated Watson / Crick pair. The 
former, which predominates at physiological pH, will be removed by 
normal proofreading and repair enzymes, whereas the latter is likely to 
escape detection. Hence, the occasional occurence of the protonated 
06MedG.dC base pair may explain why the presence of 0 6MedG in 
genomic DNA does not always give rise to a mutation. 
Synthesis of C(8) substituted 2'-deoxyguanOsine derivatives was 'also'.' 
undertaken in an effort to yield 8-oxo-7-hydro-2'-deoxyguanosine, a 
product of oxidative damage to DNA. Displacement of bromine, from 8-
bromo-2'-deoxyguanosine, was achieved with methoxide, benzyloxide and' 
-nitrothiophenol. Conversion of 8-methoxy-2'-deoxyguanosine to 8-oxo-7-
hydro2'-deoxyguanosine was achieved by use of thiophenol, however 
conversion was not possible using oligonucleotides containing the 
8MeOdG nucleoside. Oligonucleotides containing 8-bromo-2-
deoxyguanosine were synthesised which demonstrated similar pairing' 
properties to oligonucleotides containing 2'-deoxyguanosine. As a result 
•8BrdG was utilised as a heavy atom marker in the crystal structure of 
the DNA drug complex of d{T8BrGTAQA] / nogalomycin, thus aiding the 
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dR 	 2'-deoxyribose. 
EDTA 	 ethylene diamine tetraacetic acid. 
FAB-MS 	Fast Atom Bombardment Mass Spectrometry. 
HPLC 	 High Performance Liquid Chromatography. 
lb 	 isobutyryl. 
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ip 	 isopropyl 
mCPA 	 2-cyanoethyl-N-N'-diisopropylphosphor.. 
amidochioridite. 




dd. doublet of doublets. 
exch. exchangeable. 
m. multiplet. 









psi. pounds per square inch. 
Rf. Relative front. 
Sh. 	 shoulder. 
T 	 thymidine. 
TEA 	 triethylamine. 













d < R 	O 
2'-deoxyguanosine. 	 2-deoxycytidine. 
OMe 
MeOCV-61  I# 4,4'-dimethoxyty1. 
1" -6" 
d[CGCGAATTCGCGJ 	Oligonucleotides. 
1 	 12. 
Single stranded DNA is always written and numbered from the 5' to the 3' 
direction. For example, in the above sequence dC, the 5' nucleotide, is 
numbered one and dG, the 3' nucleotide, numbered twelve. 
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1.1. Introduction to DNA. 
The extreme diversity of plant and animal life existing on planet earth is a result 
of evolutionary processes stretching back over hundreds of millions of years. The 
conditions that were present in the prebiotic world are not known and many ideas 
have been put forward. One of the earliest attempts to mimic prebiotic conditions 
was the Miller experiment, (Miller 1953), which demonstrated the synthesis of 
amino acids from simple molecules, and more recently the work of Joyce (Joyce 
1989) who attempted to understand the very complex series of reactions that 
would be necessary for the synthesis of ribonucleotides from simple molecules. It 
is now generally accepted that the process of evolution began with molecules that 
had the ability to act as templates for their own synthesis. Such molecules must 
also have possesed the ability to mutate and therefore adapt to their surroundings. 
Molecules with this ability are not easy to visualise, but some elegant work (Hong 
1992) is beginning to provide an understanding of the potential of a prebiotic 
environment. The types of compounds present, are of course unknown, but it is 
clear today that ribo- and deoxyribo- nucleic acids (RNA and DNA) are the only 
classes of compounds which have continued to prosper from such elementary 
beginnings. They are present in every single cell of all known organisms. The 
discovery of catalytic RNA (Cech 1990 and Altman 1990) has added weight to 
the argument that RNA may have been the original replicating catalyst which was 
eventually superceded by deoxyribonucleic acids (to store the information) and 
proteins (to catalyse chemical reactions). 
It had been known ever since Mendel (1822-1884) crossed round and wrinkled 
peas (Knowles, F.G.\V, that there was some hidden force which resulted in 
parental characteristics being inherited by the next generation. It was Avery, in 
1944, who established the role of DNA in this process. Establishing exactly how 
this information is securely stored and passed on to subsequent generations is not 
a trivial problem, even when one considers a simple bacterium such as E. Coli 
which is unicellular and will, in ideal conditions, repràduce through cell division 
approximately every thirty minutes. This not only requires very rapid replication 
of the genome, such that both daughter cells have a copy, but also requires easy 
access to the DNA molecule which, by design, has a very compact and enclosed 
structure in order to safely protect the genetic material from any damaging agents 
and to package the genetic information into a small volume within the cell. 
As far back as 1869, when nucleic acids were first isolated by Miescher, it was 
known that they were major constituents of cells and nuclei, hence the name 
"nucleic" (from the nucleus). Subsequent characterisation determined the presence 
of five different heterocyclic bases, two types of sugar rings and a phosphate 
group. Together these three subunits form the monomer nucleotide units (Figure 
1.1a) which, when condensed together, (Figure 1.1b), create the polymeric 
structures of DNA and RNA. One of the biggest stumbling blocks in establishing 
the structure of DNA was that the correct tautomeric forms of the four 
heterocyclic bases A, G, C and T were not known. However the fact that in every 
DNA sequence analysed the A:T and G:C ratios were always around 1:1 
[Chargaffs law (A+G)=(T+C)} suggested a very special relationship between the 
purine and pyrimidine nucleotides (Chargaff 1950). With aid of the fibre 
diffraction data of Franklin and Wilkins, Crick and Watson finally analysed all 
the available data and correctly determined the structure of B-DNA, publishing 
their findings in Nature (Watson and Crick 1953). By recognising the helical 
symmetry of the molecule they were able to establish that the bases, in their 
correct tautomeric forms, hydrogen bonded in a pseudo symmetric manner, 
2 
Figure 1.1a. 
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= Pseudodyad relating glycosidic bonds. 
The structure of DNA consists of two strands which wind round each other in an 
antiparallel manner to yield a double helix with complementary hydrogen 
bonding holding the two strands together. The elegant symmetry and compactness 
of B-DNA can be seen from the various views, (Figure 1.3), which illustrate how 
the base pairs stack at the centre of the helix with the two phosphodiester- sugar 
backbones winding around the outside. This gives rise to two continuous grooves 
in the duplex which, owing to their different dimensions, are termed the major 
and minor grooves. Hydrogen bonding complementarity between the four bases 
was the crucial discovery which led to the structural determination which 
established that only A.T, T.A, G.0 and C.G base pairs were possible. This not 
only explained the reasoning behind Chargaffs' law but also suggested a 








DNA side view 
helix can unwind allowing each strand to act as a template for the synthesis of its 
complementary partner thus giving rise to two daughter copies of the original 
duplex. In 1968, Nirenberg, Ochoa and Khorana determined that DNA directed 
protein synthesis via a triplet code, with each block of three bases, called a codon, 
representing one amino acid. Thus the DNA sequence of a gene determines the 
amino acid sequence of the protein it codes for. Expressing the genetic code 
requires only one strand of DNA, the sense or template strand, which is copied 
into a complementary copy of messenger RNA (mRNA) which in turn directs 
protein synthesis. at the ribosome (Figure 1.4): note the use of U instead of T in 
RNA. 
Figure 1.4. 
Double stranded DNA. Template strand. 
\ 	Messenger RNA. 
'I 
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It has now been well established that eukaryotic DNA is stored in the nucleus of 
the cell, in a supercoiled form on pairs of chromosomes, containing around 106 - 
108 nucleotide base pairs each, which store all the information necessary not only 
to direct protein synthesis but to exercise control over the growth, division and 
differentiation of cells. This diversity of function is attributed to the flexibility of 
B-DNA which is able to interact with proteins and small molecules which control 
the mechanisms by which genes are switched on and off. 
Despite the many advances in the four decades since B-DNA was first 
characterised many of its functions are still unknown. Only when the mechanisms 
for gene regulation I expression, cell differentiation and division are understood at 
the molecular level will it be possible to address such problems as mechanisms by 
which proto-oncogenes are converted into oncogenes, resulting in the 
development and uncontrolled growth of cancerous cells. A major development 
over the last decade, which has enabled such questions to be addressed in much 
more detail, has been the automation of DNA synthesis (Beaucage 1992). This 
powerful technique has facilitated work with larger and purer amounts of DNA of 
defined • sequence, allowing techniques such as n.m.r. and X-ray crystallography 
to be used to investigate DNA structure in detail. Another advantage is that 
oligonucleotides containing non standard base pairs, eg. A.0 and T.G, and 
modified bases, such as 5-Methyl dC and 5-Bromo dU, can be investigated and 
their effect on the helix geometry and oligonucleotide stability established. 
Oligonucleotides bound to drugs can be crystallised, (Leonard 1992a and Kennard 
1991), thereby yielding information about DNA drug recognition and the very 
complex problem of drug design. X-ray crystallography has provided some 
ground rules for DNA structure by establishing the various helical forms of A,B 
and Z DNA as well as the characterisation of a variety of sequences containing 
non-complementary base pairings. This has given an insight into the diversity of 
inter base hydrogen bonding and the ability of the helix to accommodate 
structural variations. 
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The importance of DNA in biology cannot be over emphasised and its role as a 
store of genetic information has been widely exploited in recent years, in 
techniques such as site directed mutagenesis (Taylor 1985), DNA fingerprinting 
(Joyce 1990) and in the use of antisense oligonucleotides to inhibit gene 
expression (Agrawal 1992). Developments in DNA sequencing, (Sanger, F. 
1977), have led to the recent publication of the entire DNA sequence of yeast 
chromosome m (Oliver 1992) which contains 315 kilobases. Such work will 
undoubtedly contribute to our understanding of cellular processes which operate 
in both simple and complex organisms. 
1.2. DNA structure and function. 
Although many interactions between DNA, RNA and proteins have been 
characterised, many others are still not very well understood, yet are known to 
play a pivotal role in a variety of intracellular processes. A good example of the 
interplay between all three molecules is found in the series of reactions 
responsible for replication of the genetic code, (Figure 1.5), which is one of the 
most important events in nature. A huge variety of proteins are involved, eg. 
DNA helicase, helix destabilising proteins and DNA polymerase, for destabilising 
the double strand, stabilising the single strand and synthesising the daughter copy. 
RNA is also necessary as a primer on the lagging strand of the replication fork, 
possibly forming an RNA / DNA helix which can then act as a substrate for the 
DNA polymerase which only synthesises in the 5' to 3' direction. The entire 
process is also monitored by a variety of enzymes which ensure that the two 
daughter copies are synthesised complementary to the template strand. The 
fidelity of synthesis is such that there is only one wrong base in every 109 
insertions (Fowler 1974). 
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supercoiled helices. This is the form in which DNA is stored in the nucleus of the 
cell as chromosomes, which consist of one long DNA molecule Ca. 4 cm long 
compressed into fibres of Ca. 25 nm wide by 700 p.m long. This extremely dense 
structure of DNA is stabilised by proteins called histones which wrap the DNA up 
into very tight disks. When protein synthesis occurs an area of the chromosome is 
opened out and the double stranded B-DNA helix is exposed. DNA structure has 
profound implications for expression of genes and the control that DNA 
ultimately exerts over cellular processes as a whole, since in its active form DNA 
displays a wide range of structures with triple helices, cruciforms, hairpins and 
kinks all known to occur (Wells 1988), which may in some way be involved in 
the recognition processes involved in gene regulation. It has been well established 
that proteins recognise the double helical nature of DNA, often through a helix-
turn-helix or a zinc finger motif (Alberts 1989), which have the ability to slide 
into the helical grooves under certain conditions, such as when small molecules or 
cations bind to the protein, and this leads to very tight binding to the DNA helix. 
Such processes are utilised by a class of protein molecules which activate or 
9 
repress gene expression by binding tightly to the promoter region of the gene. An 
example of repression, (Figure 1.6), shows how the genes coding for tryptophan 
synthesis proteins are inactivated when levels of tryptophan are high. 
Figure 1.6. 
	
No binding of repressor = active gene. 




Binding of repressor = inactive gene. 
	 No protein synthesis. 
= Tryptophan repressor protein. 	- - = Promotor region. 
= Tryptophan. 	 - = Gene. 
The tryptophan binds to the repressor protein causing an allosteric change which 
enables it to bind tightly to the promoter region and prevent the binding of RNA 
polymerase to the single stranded DNA, thus preventing transcription and protein 
synthesis. When levels of tryptophan are low, competition for protein binding is 
diminished and the repressor loses its affinity for the DNA allowing RNA 
polymerase to bind and the gene to be activated. This process prevents the 
wasteful synthesis of the proteins, which are only required when levels of 
tryptophan are low and saves the energy resources of the cell by allowing amino 
acids to be recycled more efficiently. 
In some way therefore, the protein must be able to distinguish between certain 
DNA sequences in order for it to bind specifically to the promoter region. This is 
certainly controlled to some extent by hydrogen bonding to functional groups on 
10 
the base edges (Fliess 1988), but it is also possible that local tertiary structure may 
enhance this recognition. DNA is capable of forming very subtle tertiary 
structures which are a direct result of inter and intra strand base / base interactions 
finely adjusting the helix geometry in an effort to resolve the local steric clashes 
of functional groups created by certain, base sequences. The forces of hydrogen 
bonding and base stacking are the horizontal and vertical forces, respectively, 
between the bases within the duplex and are the major contributors to geometry. 
Thus it can be said that DNA and RNA are not conformationaly homogeneous 
molecules since the observed structure is dependent upon the base sequence. 
1.2.1. Hydrogen bonding. 
Inter-strand hydrogen bonding holds the two strands of the duplex together. The 
enormous number of hydrogen bonds present, in even a small length of DNA, 
ensures that globally the two strands are held very tightly together and there is no 
possibility of them coming apart. The very fact that hydrogen bonding is by 
nature a fairly weak interaction, varying from 3-6 kcalJmol, does however mean 
that short sections of DNA can be easily opened into single strands allowing the 
information to be efficiently accessed without affecting other parts of the helix. 
The beautiful symmetry of B-DNA (Figure 1.3), is a direct result of the 
complementary hydrogen bonding across the helix axis, which holds the duplex 
together giving it a psuedo two fold axis of symmetry. With two antiparallel 
strands the dyad symmetry is restricted to the C1'-N (glycosidic) bond and is not 
applicable to the actual bases, hence it is called a pseudodyad. Such a high degree 
of pseudo symmetry is only possible if, as is usually the case, the strands can form 
the naturally pseudo symmetric Watson / Crick pairs, (Figure 1.2.). The 
hydrophobic planar bases are stacked up the core of the helix, to the exclusion of 
water, whereas the negatively charged hydrophilic phosphodiester-sugar 
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backbone winds around the outside of the helix where it can interact with water 
and cations which are always present in -vivo. This interaction with water has a 
pronounced effect on the overall structure of the helix since at high, (90%), 
humidity it forms a B helix with each phosphate groups hydrated by individual 
water molecules. At lower, (70%), humidity the helix exists in the more 
contracted A form whereby the phosphates are too close to be complexed by 
individual water molecules and are stabilised by bridges of water molecules 
between neighbouring phosphate groups. The separation between the phosphate 
atoms, on neighbouring bases of the same strand, is reduced from 700 pm to 550 
pm, and is accompanied by an alteration of the puckering of the sugar moiety 
from C2'-endo to C3'-exo (Figure 1.7). It is of interest to point out that to date 
double stranded RNA has only been found to exist as an A-form helix, which is 
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N 
* 
CT - endo. 	 * CT - exo. 
because of the 2'-hydroxyl functionality. Many short sequences of DNA have 
been characterised by X-ray crystallography in A, B and Z-DNA forms, for 
review see (Kennard 1991 and Wing 1980). 
V1IO9(01Mt 
It would appear however, from this
A 
 work, in conjunction with NMR, that the 
structural diversity of DNA is primarily due to the flexibility of the B-helix and 
its ability to accommodate minor perturbations, whereas the more rigid A-helix is 
found to be less flexible (Saenger 1984). There is also a well characterised spine 
of hydration in the minor groove of the AATT region of the B form 
12 
d[CGCGAATTCGCG] dodecamer (Kopka 1983 and Drew 1981). It is thought to 
play a significant role in stabilising the B conformation by preventing it from 
opening out into a shallow groove which is more characteristic of the A form 
helix. It is particularly important in such dA.T rich regions, which are known to 
depart from the usual Watson / Crick geometry by inducing bending along the 
helical axis (Nelson 1987). 
In addition to the four Watson I Crick base pairs, many other pairings are possible 
which can have dyad, pseudodyad or no symmetry but which destabilise double 
stranded DNA. Such non standard base pairs have been incorporated into 
otherwise self complementary sequences to give double helical oligonucleotides 
with two mispairs, example d[GGGIjCCC]. which is a self complementary 
oligonucleotide which forms an A-DNA duplex containing two T.G mispairs in 
the centre (Rabinovich 1988). The high resolution structure of this, and other 
related sequences, have been determined by X-ray crystallographic methods and 
two mismatched base pairs, characterised from such studies, are illustrated below, 
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Protonated dA (anti) : dO (syn) 
The dG.T mispair, (Figure 1.8a.), is held together by two hydrogen bonds. In 
order to acconodate them however, it is necessary for the thymine base to move 
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into the major groove thus forming what is termed a wobble base pair. As a result, 
the pseudodyad symmetry of the base pair is lost, (compare with the dG.dC and 
dA.dT pairings in Figure 1.2 which maintain pseudo-symmetric centres). In 
contrast the dA.dG mispair, (Figure 1.8b.), maintains its pseudo symmetric 
centre, also displaying conformational variability as a function of the pH of the 
solution (Gao 1988). Base stacking also plays a very important part in the 
geometry and structure of this mismatch, and this effect is discussed in the next 
section, 1.2.2., (Brown 1989 and Brown 1986). 
The variations observed for this mismatch are in part due to the syn I anti 
conformational change that is possible around the C1'-N glycosidic bond, (bold 
bond in Figure 1.9), and in purine bases this allows alternative hydrogen bonding 
N and 0 atoms to be presented to the opposing base. 
Figure 1.9. 
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dA (anti). 	 dA (syn). 
This syn / anti rotation permits a variety of dG.dA pairings, of which four have 
been characterised (Ying 1991, Brown 1989 and Brown 1986 ). One of them, 
dG(syn).dA(anti), (Figure 1.8b), is held together by two hydrogen bonds, one of 
which is only made possible by protonation of the dA-N(1) atom, and rotation of 
the dG base into the syn conformation. This base pair utilises the N(7) and 06 
hydrogen bonding sites of dG which are complementary to the N6  and N(1) atoms 
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of protonated dA. The separation between the Cl' atoms of the dG and dA 
deoxyribose sugars is approx. 11 A. This is close to the value for a Watson I Crick 
base pair (10.1 to 10.8 A) and so ensures that the helical diameter is maintained 
without disruption of the phosphodiester backbone. It is however a 
thermodynamically unstable helix, T. = 293°K (pH 7.75) and 31 10K (pH 5), and 
crystallisation of this form of mismatch is only possible below physiological pH 
where the base pair is able to form the hydrogen bond involving the protonated 
N(1) atom of dA which is necessary for stabilisation of the helix (Brown 1989). 
The conformational variability of the dG.dA mismatch illustrates the variety of 
methods employed by DNA to accommodate unusual structures into the local 
helical geometry by fully utilising the limited number of functionalities in the 
heterocyclic bases capable of participating in hydrogen bonds. 
Such mispairings, as illustrated in Figurel•8, provide a mechanism for DNA 
mutation. An alternative mechanism, via • formation of base pairs which contain 
- one of the bases as a minor tautomer is shown below, Figure 1.10. 
Figure 1.10a. 
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dA(imine) . dC 
In this situation a dG can pair with a T base in the enol tautomeric form to form 
three stable hydrogen bonds and a dA imine tautomer can pair with dC to form 
two stable hydrogen bonds. Both provide a mechanisim for the incorporation of a 
different base sequence into the daughter strand at the next round of replication. 
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The alternative form, dG(enol).T and dA.dC(imine) will have the same effect. 
The almost exclusive formation of Watson / Crick base pairs in DNA is extremely 
important during replication and it is still unclear how enzymes are able to detect 
mismatches so efficiently in spite of the tremendous variety of mismatch 
structures that can form. Variable hydrogen bonding patterns are far more 
extensively utilised in RNA molecules than in DNA. RNA displays extreme 
conformational flexibility due to the presence of the 2' hydroxyl group which 
enhance its hydrogen bonding capabilities. This enables it to fold into a variety of 
very complex single stranded tertiary structures and consequently RNA has many 
more diverse functions in biology than DNA. It is utilised in ribosomes, which are 
large RNA molecules containing three RNA binding sites and which synthesise 
proteins of sequence defined by the bound mRNA strand (Alberts 1989). A 
further demonstration of the diversity of RNA is demonstrated by ribozymes 
which are highly specialised RNA molecules having a well defined tertiary 
structure and are capable of catalysing intra-strand phosphocliester bond cleavage 
(Cech 1986). 
1.2.2 Base stacking. 
Hydrogen bonding controls the recognition that enables two complementary 
strands to form a double helical structure. However, after initial nucleation of Ca. 
three base pairs the vertical base stacking interactions further stabilise the 
complex and promote full duplex formation (Porschke 1977). These interactions 
are extremely important in determining the secondary structure, which therefore 
depends upon the the DNA sequence. The situation regarding mRNA and tRNA 
is complex due to the extensive use of hydrogen bonding to maintain structural 
integrity. In certain DNA sequences, such as inverted repeats or G rich regions, 
intra strand hydrogen bonding and base stacking can occur to give the fairly well 
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defined structures found in telomeres and hairpins (Kang 1992 and Howard 
1991). The subtle perturbations imparted by stacking within the duplex, which are 
very dependent upon the base sequence involved, ensure that the planar base 
moieties are stacked in such a way as to keep interaction with water and steric 
clashing of functional groups to a minimum, thus lowering the free energy of the 
system. Stacking forces depend upon; dipole / dipole, dipole I induced dipole 
interactions and London dispersion forces (Atkins, P. N, as well as interactions 
between the it-electron systems and hydrophobic effects (Hanlon, S. 1966 and 
Herskovits 1963). The sequence dependence of base stacking effects can be seen 
quite clearly from the stacking energies of all the ten possible base pair dimers, 
which have been calculated in vacuo (Ornstein 1978). These results clearly 
demonstrate the importance of sequence on the energy of stacking, and the 
following general rule applies: 
5'-Pyrimidine-Purine-3' more stable than 	5'-Purine-Pyrimidine-3' 
This is typified by the 5'-CG-3' dimer which is 5 kcal/mole lower in energy than 
the 5'-GC-3' dimer, and is a direct result of the lack of overlap found between 
bases when the pyrimidine is found on the 3'- side of a purine base (Arnott 1974). 
This effect is only valid for the B-DNA form since base pair tilting, propeller 
twisting and helical rise per residue vary for each form and have a major effect on 
the base stacking potential (Dickerson 1983). For example pyrimidines situated 3' 
to purines give rise to functional group clashes in the minor groove which can 
only be alleviated by local opening up of the helix by bending of the DNA 
towards the major groove. Such bending of the helix has been shown to be 
recognised by certain restriction endonucleases which preferentially cut at TpA or 
CpG steps. The sequence recognised byEcoRV, for example, is GAITC, and 
cutting occurs between the underlined bases. It has been demonstrated however 
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that EcoRV binds to all sequences with equal affinity (Taylor 1991) but will Cut 
only at the TpA step because of preferential binding of Mg2+ to this DNA / 
enzyme complex. The catalytic behaviour of this enzyme has also been studied 
using modified nucleotides in the vicinity of the TpA region, and the results have 
shown the importance of cytidine and adenine amino groups for enzymic activity 
(Fliess 1988). It is therefore conceivable that slight bending of the helix, coupled 
with recognition of the flanking bases, induces a conformational change in the 
enzyme / DNA complex which allows binding of Mg2+ and thus catalysis of the 
reaction. There is almost no affinity for Mg2+ binding at other sites (Taylor 
1989). 
It has also been observed that stacking plays a very important part in the crystal 
packing of free nucleosides, with the stacking pattern varying widely depending 
upon the nature of the parent molecule. Stacking interactions observed for 
guanosine (Bugg 1968) are shown (Figure 1.11a), and inosine, which lacks the N 2 
amino group, follows the same pattern. On the other hand the crystal structure of 
8-bromo-2'-deoxyguanosine shows a completely different stacking pattern to that 
of the parent molecule, (Figure 1.11b), (Bugg 1969). 
Figure 1.11a. 
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8-Bromoguanosine. 
The introduction of the very electronegative bromine atom creates a polarisable 
bond which is able to interact with the it-electron system through an inductive 
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effect (Waliwork 1961) and as a result the base stacking is completely altered 
The effect of the stacking environment on the structure of individual base pairs 
can be highlighted by the differences in structure of dG.dA mispairs found in the 
following pair of related dodecamers: A) d[CGCjAATI'AGCG] and ) 
d[CGCAAATT1GCG]. Sequence  A gives rise to a dG(anti).dA(syn) mispair 
whilst R results in formation of a dA(anti).dG(syn) mispair. The flexibility of this 
mismatch has been demonstrated through NMR experiments (Gao 1988), and it is 
clear from this and the crystal structure results, that base stacking effects, along 
with pH variation, influence the conformation. This demonstrates the ability of 
flanking bases to exert pressure on the mismatch forcing the bases to adopt the 
conformation most able to enhance the duplex stability. In the dG(anri).dA(syn) 
mismatch, (Figure 1.12), the dG involved is part of a CpG step which is known to 
be the most stable stacking step in B-DNA (Ornstein 1978), and is almost 
certainly partly due to the fact that cytosine and guanine have dipole moments of 
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dG (anti) . dA (syn). 
In sequence B however, this stable stacking is not present because the dG is now 
part of a GpG step and so unfavourable dipole interactions are best relieved by 
rotation of the guanine into the syn conformation which will more favourably 
align their static dipole moments, to yield the protonated base pair shown in 
19 
Figure 1.8b. This alignment is illustrated by the crystal structure of guanine which 
stacks as in Figure 1.lIa. 
1.3 DNA modifications. 
DNA has a large number of functional groups, ie: keto, amine and hetero atoms, 
capable of reacting with a wide variety of chemicals. Although all exocyclic 
groups and hetero atoms, with the exception of the nitrogen attached to the sugar, 
are available for reaction (Blackburn 1986), modification of heterocyclic bases is 
much more common than that of the sugar or phosphate group since it is thought 
that disruption of the very stable phosphodiester backbone may inhibit the 
formation of double helical DNA, and hence such alterations are easily recognised 
and repaired. In addition, sugar / backbone modifications often lead to cleavage of 
the strands, a lesion which is also very easily recognised and repaired. The most 
common chemical modifications involve nucleophilic attack on electrophilic 
alkylating agents by heterocyclic bases. These are the most extensively found 
potentially mutagenic modifications. 
Figure 1.13a. 
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Modifications of this nature also occur naturally in tRNA (McCloskey 1977) 
where enzymes selectively modify the RNA nucleotides in order to convert the 
tRNA into a functional molecule. Other derivatives such as 5',3' cGMP and 
NADH are utilised as secondary hormonal messengers and enzyme cofactors 
respectively. (Figure 1.13). 
1.3.1 Phosphate and sugar modifications. 
Research into the synthesis of novel nucleosides has expanded greatly in the last 
decade, largely due to the isolation of the Human Immunodeficiency Virus (HIV) 
in 1982, and hundreds of nucleoside analogues have been prepared and evaluated 
as anti-HIV agents. HIV is the virus responsible for AIDS (Montagnier 1988), 
and it belongs to a class of viruses known as retroviruses because its genetic 
information is stored as RNA as opposed to DNA. In order for the virus to 
complete its lifecycle (Figure 1.14), ie. to create more viral particles, it is first of 
all necessary to convert its information into double stranded DNA. After fusion of 
the virus with the host cell, viral DNA is synthesised by the enzyme reverse 
transcriptase which uses both viral tRNA, as a primer, and viral RNA as a 
template for the synthesis of a DNA / RNA hybrid. Subsequently a DNA / DNA 
duplex is synthesised which is then integrated into the host genome where it can 
remain dormant for many years before transcribing its information and producing 
new viral particles which results in lysis of the host cell. This very subtle lifecycle 
of lilY explains the difficulty in controlling its spread since anti-HIV drugs must 
be harmless to uninfected cells. The enzyme reverse transcriptase, which is 
injected into the host cell along with the RNA inside the virus particle, is a good 
target for this inhibition strategy because it is unique to the infected cells. It is not 
a particularly selective polymerase (Preston 1988), as abnormal nucleotide 













than into host DNA which is synthesised with the aid of cellular polymerases. 
Currently, the most potent inhibitor of reverse transcriptase is 3'-azidothymidine 
(Figure 1.15a), a thymine analogue which when attached to a growing DNA 
strand cannot support chain elongation due to the absence of the 3'-hydroxyl 
group, thus polymerisation ceases and only short fragments of DNA are produced. 
3'-Azidothimidline is incorporated into viral DNA 100 times faster than host DNA 
which is synthesised by cellular polymerases (Yarchoan 1988). Acyclovir, (Figure 
1.15b), is an inhibitor of Herpes Simplex Virus (HSV), and in this case selectivity 
to virally infected cells arises from the fact that it can act as a substrate for HSV 
thymidine kinase but not for cellular thymidine kinase. Thymidine kinase is the 
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enzyme responsible for the phosphorylation of nucleosides to produce their 
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In both AZT and acyclovir the active compounds are the nucleotide triphosphates 
which are the substrates for the polymerase enzymes and can be incorporated into 
the growing strand. Although extremely potent, these drugs do not produce cures 
and their quick turnover in-vivo means that they must be administered daily. Thus 
treatment is long term and very expensive. 
An alternative antiviral strategy is known as the antisense approach which 
involves the synthesis of an oligonucleotide >17 bases long which has a 
complementary sequence to a coding region of the viral genome. This subject has 
been extremely well reviewed recently (Uhlmann 1990). The antisense strategy 
works by the binding of an oligonucleotide to mRNA to prevent protein synthesis 
at the ribosome, or by binding of an oligonucleotide to the genomic DNA by triple 
helix formation, thus preventing synthesis of mRNA (Riordan 1991). Although 
both methods of inhibition are perfectly acceptable models for arresting the viral 
life cycle, progress in this area has been fraught with difficulty due to the inability 
of the oligonucleotides to penetrate the cell membrane as well as their lack of 
resistance to degradation by DNase enzymes both inside and outside the cell. 
Many chemical modifications have been made to antisense oligonucleotides to 
combat these problems, mainly the incorporation of large lipophilic molecules 
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such as vitamin E and cholesterol (Will 1992 and Stein 1991) in an effort to 
improve transmembrane transport, and the incorporation of phosphorothioate 
groups to prevent cellular degradation, (Figure 1.16), (Ott 1987). Another 
interesting approach has been the attachment of intercalating molecules such as 
psoralen and acridine to oligonucleotides (Englisch 1991), such that the site of 
intercalation is controlled by the oligonucleotide binding in a triple helix fashion 
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Other strategies have been devised in an attempt to couple improved lipophilicity 
with nuclease resistance. Oligonucleotides have been synthesised containing a 
neutral backbone (Matteucci 1990 and Sood 1990). A combination of improved 
lipophilicity and nuclease resistance has been achieved, although many questions 
still remain as to the mode of action of these analogues (Agrawal 1992). Such 
molecules do however have very good potential as antisense agents and this has 
been demonstrated by their efficacy when microinjected into infected cells. 
13.2 Heterocyclic base modifications. 
Transfer RNA is an extremely rich source of unusual ribosides (Figure 1.17). The 
most common modification involves the conversion of a keto group into a thiol 
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purine-6-y1)carbony1]threonine. 
Modified ribosides are present at particular sites throughout tRNA molecules but 
are clustered predominantly around the anticodon domain. They are necessary for 
enhancing the codon I anticodon interactions with the modification being 
dependent upon the first nucleotide of the codon it recognises in the mRNA 
sequence. In particular, the flanking base to the codons exhibit the greatest variety 
of modifications, for example codons starting with a U almost always contain 
hydrophobic modifications, eg. N 6-isopentenyladenosine, whereas tRNA 
recognising codons starting on A contain hydrophilic modifications such as N-[N-
(9--d-ribofuranosy1purin-6-yl)carbamoyl] -threonine. Modified bases at other 
locations may also promote the formation of very precise tertiary structure by 
blocking and enhancing hydrogen bonding sites that are important in the 
formation of base triplets (Altman). In addition modified bases inhibit the 
degradation of tRNA by RNase enzymes. 
Synthetically prepared nucleoside derivatives containing reactive functionalities, 
eg. sulphur or azido, can be incorporated at specific points in a sequence and are 
particularly effective at promoting intra strand and DNA / protein crosslinking 
(Glick 1991 and Meffert 1990). Meffert synthesised 8-azidoadenine and 
incorporated it into a sequence containing the tetracycline repressor binding 
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domain. Binding of the repressor followed by long wave irradiation yields a 
protein-DNA crosslink which is easily visualised on gel electrophoresis. It has 
also been used in its triphosphate form to probe the deoxynucleotide binding 
domain of the enzyme DNA polymerase (Joyce 1987). This methodology 
therefore has the potential to provide information about protein binding domains, 
tolerance of DNA modifications on protein binding and also kinetics of gene 
repression / derepression. On the subject of the evolutionary development of 
DNA and RNA as replication systems, much work is currently underway on the 
introduction of novel, but complementary base pairs, which can extend the 
genetic alphabet beyond the four Watson I Crick base pairings (Piccirilli 1990). 
A more detrimental aspect of nucleoside modification, discussed in the next 
section, is the formation of derivatives which contain an altered hydrogen 
bonding pattern with respect to the parent compound and thereby lead to the 
formation of mutagenic lesions. The synthesis of such nucleosides is extremely 
important and the effect they have on double helical DNA must be investigated 
thoroughly so that their mutagenic potential can be accurately assessed. The 
crystal structure, (Leonard 1992b), and NMR analysis, (Patel 1986), of such 
sequences gives us an insight into the altered hydrogen bonding, base stacking 
and base orientations which cause mispairing or reading frame errors and lead to 
mutagenic lesions in DNA. 
1.4. Alteration of the genetic code. 
As mentioned briefly in section 1.2, the outstanding accuracy of DNA replication 
is such that only one base in every 109 insertions results in a mutation in the 
daughter helix. Mispairings, such as dA.dC or TAG pairs, do not normally persist 
all the way through the replication cycle and give rise to mature DNA because a 
variety of mechanisms have evolved in cells to counteract this problem. Initially 
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the base selection is achieved through the parent strand acting as a template for 
incoming nucleoside triphosphates, which, when they match the complementary 
hydrogen bonding pattern are attached to the 3' end of the growing chain. This is 
however a very crude method of selection since it is based solely on the energy 
difference between a complementary and a non-complementary base pair during 
DNA synthesis, which is around 3kcal/mole ie. the equivalent of one hydrogen 
bond (Loeb 1981). Therefore, the presence of minor tautomers, which have a 
frequency of Ca. 10-5, and base mispairings can cause the normal rules of Watson 
/ Crick complementarity to break down, resulting in an initial misinsertion 
frequency of 10-2 to 10-4. The most important controlling influence on overall 
fidelity is the DNA polymerase protein itself which has both a 3'-5' and 5'-3' 
exonuclease domain with the ability to recognise base mispairs, cut them out and 
insert the correct base to lower the error rate to an acceptable level. 
Since genes are made up of non-coding lengths called introns and coding lengths 
called exons, depending upon where a mutation occurs it may or may not directly 
affect the integrity of the cell. All mutations, however, regardless of their effect 
can be classed as either transition mutations (arising from the pairing of a purine 
with the wrong pyrimidine) or transversion mutations (arising from the pairing of 
two purines). The twelve possible base pair conversions are shown, (Figure 1.18). 
Figure 1.18. 
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Transversion mutation. 	 Transition mutation. 
When such a mutation occurs in an exon region it is known as a point mutation 
and has the potential of altering the amino acid sequence due to a change in the 
27 
triplet code. When it occurs in an intron region that is in the vicinity of a gene, eg. 
the promotor region, then it is termed a regulatory mutation since the introduction 
of a different base in such an area may have the effect of determining whether the 
gene is active or not. An interesting aspect of DNA mutations has been their use 
in establishing a timescale for the divergence of various species (Alberts 1989). In 
all species, mutations will build up at a steady rate, thus when the relationship 
between frequency of mutation and time is established an estimate can be made of 
the lineage of the species. Within humans the relatively fast rate of mutation in 
mitchondrial DNA has been used in an attempt to establish the timescale of 
divergence of modern man and Neanderthal man into the present day races 
(Vigilant 1991). 
Persistence of mutagenic base pairs is closely related to their ability to mimic 
normal Watson / Crick base pairs in terms of their overall geometry in relation to 
the helix. The three mispairs illustrated in Figure 1.19 are all repaired to varying 
degrees. The dG.T and clA.dC wobble pairings, whose geometry least closely 
resembles a true Watson / Crick pair (Fersht 1982), are repaired more frequently 
than the dA(syn).dG pairing (repair ratio of 15:5:1) which is most likely to escape 
detection by the proofreading enzymes. 
In a crystal structure of the dA.dC mismatch (Hunter 1986) it is noticeable that 
the mismatch has a major impact on the stacking properties of the adjacent dC(3) 
dG(21) bases which are altered from the norm, and it is entirely possible that if 
this event were to occur in-vivo then misreading could also occur at those 
positions. 
Although mutations slowly accumulate from one generation to the next, there is a 
certain amount of self regulation because the pressure to mutate a particular base 
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of an enzyme will show almost no tolerance of mutation whatsoever since any 
change would most probably result in the enzyme working less efficiently. For 
the same reason, residues involved in protein folding will show similar resistance. 
Amino acids in less structurally important regions of the enzyme, such as side or 
linking chains, will however be much more susceptible to change as any changes 
may not directly affect the integrity of the enzyme. Thus the protein sequence, of 
for example haemoglobin, from a variety of animals shows areas of strong 
conservation in the structurally important regions but little or no conservation in 
structurally inactive portions. This disparity is often used to establish time scales 
of species divergence. It is important to point out however that in principle all 
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areas of a protein, eg. an enzyme, are subject to the same frequency of mutation, 
it is just that when they occur at substrate binding sites they will usually be 
detrimental to the organism and the mutation will not be maintained in the gene 
pool. This "protein survival of the fittest" therefore ensures that detrimental 
mutations are cast aside whilst beneficial ones are maintained due to optimisation 
of the enzyme's catalytic activity. 
An excellent example of how environmental pressure selects in favour of 
mutations is found in inhabitants of West Africa, where malaria is prevalent. It is 
therefore beneficial to be able to withstand the mosquito borne attacks of the 
parasite responsible for malarial infection. Consequently, a dG.dC to T.dA 
transversion mutation in the gene coding for human haemoglobin, has resulted in 
the conversion of a single d(GGA) triplet coding for glutamic acid, to a d(GTA) 
triplet which codes for valine. This incorporation of valine instead of glutamic 
acid results in the blood corpuscles becoming less saucer shaped than normal, 
making them less susceptible to invasion by the parasite (Smith 1975). This 
mutation also has a detrimental effect since this "sickling" of the corpuscles can 
block blood vessels and this in turn may lead to anaemia and even death. It is 
important to point Out however, that although this mutation is both beneficial and 
detrimental, it has survived in the population because it has given them some 
resistance to malaria, which causes far more deaths than sickling. 
Mutations causing gene alterations, such as described above, give rise to problems 
such as Cystic fibrosis (Cheng 1990 and Gregory 1991) and Tay-Sachs disorder 
(Lau 1989) which are illnesses resulting from the inheritance of a defective gene. 
The resultant protein is structurally different and this can prevent full maturation 
leading to disruption of the usual protein trafficking mechanisms. 
In summary, there is a low background level of mutation which gives rise to a 
large gene pool within a species and enables it to respond quickly to changes in 
environmental factors. If replication was 100% faithful then no evolution would 
have been possible due to the absence of a mechanism for improvements through 
preferential selection. Despite these errors in copying, inheritance of genetic 
material from one generation to the next proceeds very faithfully with mutations 
occurring fairly infrequently. The study of genetic inheritance is therefore carried 
out on species such as Drosophila melanogaster which have short life spans 
allowing many generations to be studied over a period of a few months (Garcia-
Belido 1979). Such studies yield information that allows genes to be accurately 
mapped out, ultimately increasing our knowledge of proto-oncogenes and 
hereditary defects. 
1.5. Mutation through DNA damage. 
Base mispairs which escape detection by polymerase and repair enzymes account 
for a very small number of mutational lesions and merely maintain a certain 
background level. A much more serious threat to the genetic integrity of DNA 
arises through chemical or physical damage, particularly during processes such as 
replication, transcription and recombination where the genome is partially 
denatured from proteins in its densely supercoiled form into the more accessible 
protein free double stranded form. As a result of the constant presence of 
mutagenic agents in the environment, which affect not only DNA but many other 
biological molecules, a variety of detoxifying compounds and repair enzymes 
have evolved to prevent and repair damage caused by this constant daily 
exposure. Acute attacks from radiation exposure and ingestion of toxic chemicals 
can however completely overload these defence systems leading to cellular death, 
through damage to proteins, DNA and consequently tissues. The interactions of 
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physical and chemical agents with DNA are particularly diverse owing to the 
large number of sites throughout the DNA molecule which can be easily attacked. 
Both classes of carcinogen can however ultimately react by inducing some form 
of structural change in the bases such that a mutagenic lesion is formed which has 
lost the base pairing complementarity of the parent compound. Physical damage 
for 
due txample, ionising radiation, can lead to the formation of very reactive 
oxygen radical species which can damage DNA through strand scission 
(Dizdoraglu 1975) as well as causing a variety of nucleotide modifications 
(Aruoma 1991), (Figure 1.20). 
Figure 1.20. 
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Electrophilic alkylating agents constitute the major group of chemical 
carcinogens. They are capable of reacting at a multitude of nucleophilic sites in 
DNA (Blackburn 1986). These agents are extremely diverse, from intercalative 
polyaromatic compounds such as benzo-(a)-pyrene and anthracycline drugs to 
aflatoxins and sulphur / nitrogen mustards, (Figure 1.21). 
The latter compounds are bifunctional electophiles which exploit the high 
nucleophilicity of guanine N(7) and severeiy damage DNA by crosslinking the 
two strands. The principle of chemical crosslinking of opposite strands is utilised 
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Two compounds which form mutagenic lesions are 0 6-methyl-2'-deoxyguanosine 
(06MedG) which is the result of nucleophilic attack on electrophilic alkylating 
compounds and 7-hydro-8-oxo-2'-deoxyguanosine (80xodG), which is a result of 
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8-Oxo-7-hydro-2'-deoxyguanosine. 
Both are known to be mutagenic, 06MedG specifically induces G.0 to A.T 
transition mutations (Snow 1984 and Abbott 1979), whilst 80xodG directs the 
insertion of dA or dC depending upon the nature of the polymerase (Shibutani 
1991). It is therefore very important that the mechanism for misinsertion by these 
mutagenic bases is elucidated so that a greater understanding of the onset of 
cancers can be established. Only through structural analysis at the base pair level 
can their effects on duplex DNA be investigated. 
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1.5.1. Alkylation of Guanine 06. 
Electrophilic alkylating agents are classed in two groups, those which can directly 
react with DNA, (primary carcinogens), and those which are metabolised into 
reactive compounds, (secondary carcinogens). Compounds responsible for a 
higher proportion of the mutagenic 06 alkylation almost exclusively come from 
the latter group and are typically N-nitrosouxeas and dialkylnitrosamines which 
are metabolised into very reactive alkyl diazonium ions, (Figure 1.23a). Such 
compounds are termed 'hard' electrophiles and the ratio is overwhelmingly in 
favour of N-alkylation. However there is sufficient SN 1 character for the '"of 
06 alkylation of dG to N(7) alkylation of dG to be c.a. 0. 1, with methyl-
nitrosourea as the alkylating agent (Singer 1982a). In contrast, primary 
carcinogens such as dialkyl sulphates and alkyl-alkane sulphonates, (Figure 
1.23b), are much softer electrophiles and react in typical S N2 manner such that the 
of 06 alkylation to N(7) alkylation is lowered to Ca. 0.003, with dimethyl-
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Of the five sites available to alkylation in deoxyguanosine, N(1), N2, N(3), 06 
and N(7), the 06  position is the one for which substitution produces the major 
mutagenic lesions (Singer 1982a), Such modified bases lead to the insertion of 
thymine rather than cytidine in the opposite strand during DNA replication. A 
mutagenic lesion of this nature is known in one particular example to initiate the 
onset of a malignant change in cell character through activation of the H-ms 1 
transferring oncogene (Sukumar 1983). Although N(7) methylation occurs far 
more frequently than 06  methylation (Singer 1982b) it does not generate a 
mutagenic lesion, probably because there is no change in the hydrogen bonding 
complementarity of the modified nucleoside to deoxycytidine (Nagata 1988). 
N(7)-alkylation is a particularly easy lesion to repair since it leads to strand 
scission and the resultant abasic site can be easily repaired by AP, (apurinic / 
apyrimidinic), endonuclease activity (Friedberg 1985). Figure 1.24 shows how 
N(7) methylation of dO does not alter its ability to hydrogen bond to dC since the 
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06methyl-2'-deoxyguanosine (distal). 	06methyl-2'-deoxyguanosine (proximal). 
D = Hydrogen bond donor. 
A = Hydrogen bond acceptor. 
35 
For the 06MedG derivative however, methylation effectively "freezes' the 
molecule into the "enol tautomer" such that the N(1) hydrogen bond donor site 
has been converted to an acceptor site. In addition, the orientation of the methyl 
group can be either distal, syn to N(1) which would block the Watson / Crick 
sites, or proximal, anti to N(l), which would not (Parthasarathy 1986 and 
Yamagata 1988). X-ray crystallographic data of the free base indicates that a 
distal orientation is preferred and indeed this proposition is supported by energy 
calculations which indicate that the molecule becomes thermodynamically more 
stable, by 3kcal/mol, by adopting this geometry (Yamagata 1988). Ultraviolet 
denaturation studies on self complementary dodecamers (Gaffney 1984) where 
06MedG was placed opposite dA, dG, dC and T, indicate that the 06MedG.T 
pairing is the least stable of the pairs and 06MedG.dC the most stable. All are 
however considerably less stable than Watson / Crick pairs. This agrees to some 
extent with 2D-NMR studies of dodecamers containing 06MedG opposite dC and 
T respectively (Pate! 1986a and 1986b). Figures 1.25a and 1.25c show the 
postulated pairings, with the methyl group adopting a distal orientation in both 
cases. 31p  NMR of the above duplexes indicate disruption of the phosphodiester 
backbone in the 06MedG.dC  12-mer but not in the 06MedG.T 12-mer. This is 
very interesting since it agrees with theoretical results which indicate that an 
06MedG.dT pairing is possible at the normal Cl-Cl' distance of 1.07nm whereas 
an 06MedG.dC base pair is only possible at the unusually large separation of 
1.17nm between the C1'-Cl' (Nagata 1988) and may indicate the presence of an 
06MedG.dC wobble pairing. 
The base pairs shown in Figures 1 .25a to 1 .25d, have been proposed from the 2-D 
NMR and mononucleotide X-ray crystallographic experiments discussed above. 
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dC is rotated slightly and moved into the minor- groove in order to 	mniodate 
the hydrogen bonding. It seems unlikely that the orientation of the methyl group 
will affect the pairing. With T, (Figures 1.25c and 1.25d), the situation is slightly 
more confused as it is not clear how the carbonyl oxygen lone pairs of thymine 
and guanine will interact. Figure 1.25c has only one hydrogen bond which is a 
very unlikely situation since two hydrogen bonds are normally required for the 
overall "cooperativity" of the base pair (Saenger 1984) and therefore of the 
duplex. If however there is no great repulsion between the oxygen lone pairs, 
(Figure 1.25d), then a non-wobble base pair can form. This would be consistent 
with the evidence from the 31p  NMR (Pate! 1986b). Watson / Crick hydrogen 
bonding can be proposed for the base pairs in Figure 1.26, whereby the bases 
utilise what would be their normal Watson / Crick sites. 
The only efficient form of repair of this lesion is demethylation of the 06MedG by 
the enzyme Oó-methyl guanine methyl transferase to regenerate guanine (Demple 
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indicating its early evolution. 04-Methylthymine is also a reactive substrate for 
the enzyme which repairs the lesion by transferring the alkyl group onto one of its 
cysteine residues thereby repairing the mutagenic lesion and restoring the fidelity 
of replication, (Figure 1.27). Thus 06-methyl-guanine methyl transferase is an 
inducable suicide enzyme (Sciccitano 1986). 
Figure 1.27. 
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1.5.2. Formation of 7-hydro-8-oxo-2' -deoxyguanosine. 
Radicals are utilised extensively in biology for catalysis by enzymes such as 
isopenicillin-N-synthetase and ribonucleotide reductase (Stubbe 1988) and by 
phagocytes (white blood cells) which produce peroxide, hypochlorous acid and 
superoxide to destroy bacteria that they recognise as foreign (Aruoma 1991). The 
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use of such systems has necessitated very strict control because of the destructive 
nature of these chemicals towards proteins, DNA and tissue etc. Consequently a 
variety of enzymes have evolved which metabolise radical oxygen species, for 
example superoxide dismutase, catalase and glutathione (McBride 1991) and they 
limit the damage caused by the daily dose of such agents. There are also a number 
of smaller molecule antioxidants such as ascorbic and uric acid, which are very 
reactive towards oxygen radical species (Rose 1990) but which can also 
themselves create adverse effects in vivo (Kasai 1984a). Overdoses of superoxide 
or hydroxyl radicals can occur through radiation (Dizdoraglu 1985) or exposure 
to chemicals (Kasai 1984b) which can swamp the natural defences. In addition to 
DNA damage, extensive tissue degradation can lead to the onset of diseases such 
as atherosclerosis and rheumatoid arthritis (Aruoma 1991). Hydroxyl radicals are 
extremely damaging to DNA and their ability to diffuse into the duplex can result 
in extensive strand scission and base modification. This reactivity has been 
utilised by a technique known as DNA footprinting whereby a pendant Fe(II)-
EDTA group is attached to drugs or oligonucleotides such that site specific DNA 
splicing can be induced by the addition of a reducing agent such as dithiothreitol 
to the sample (Moser 1987). Therefore presence of trace amounts of transition 
metals, iron and copper in particular, in--vivo can facilitate the production of 
hydroxyl radicals through Fenton and Haber-Weiss reactions. 
Essentially. 	Fe 2+ 	+ 	H202 	- Fe 
3+ 
+ H0 + HO. 
Such a system is employed in the Udenfriend system (Kasai 1984a) in which 
80xodG is produced in small amounts by the formation of radicals from a 
mixture of Fe2+,  ascorbic acid and hydrogen peroxide. Other known inducers of 
this deoxyguanosine derivative are aminophenols and asbestos (Kasai 1984b and 
1984c). Although radical scavengers such as mannitol and thiourea protect against 
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damage to some extent, no real mechanism for hydroxyl radical metabolism has 
been identified. The two major guanine adducts formed by hydroxyl radical attack 
are 2,6-diamino-4-hydroxy-5-formamidopyrimidine and 80xodG, (Figure 1.28.), 
and both are thought to play a role in the formation of tumours (Mallins 1990). 
Damage of this nature is being constantly repaired, and an endonuclease which 
specifically cuts out 80xodG replacing it with dG has been discovered in a 
variety of mammals (Chung 1991). Thus the initial damage decreases with time 
after the attack. 80xodG residues are then excreted in the urine, with an average 
daily excretion of around 178 residues each day per cell. The electrochemical 
activity of 80xodG can be utilised in the routine analysis of human urine samples 
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Structural studies have been carried Out which have established that the 
predominant tautomer of 80xodG is the 8,6 7diketo derivative (Culp 1989, Aida 
1987 and Kasai 1987), and not the 8-hydroxy- tautomer as had been previously 
thought. In addition, as is very common with C-8 substituted purines, the free 
nucleoside prefers to adopt a syn glycosidic orientation (Cho 1990 and Uesugi 
1977), thus it has the potential to act as a thymine analogue and pair with 
deoxyadenosine or to remain anti and pair with deoxycytidine. Replication 
experiments using 80xodG in place of dG (Shibutani 1991) have established that 
dA and dC are incorporated preferentially, but that the ratio varies with the 
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polymerase used. Most striking however is the observation that chain extension 
beyond the lesion is preferential for the dA.80xodG pair and only occurs at a 
much reduced rate beyond dC.80xodG. This is in contrast to earlier work, 
(Kuchino 1987) which indicated that gross misreading occurred at the 80xodG 
site and the flanking bases. The insertion of deoxyadenosine and deoxycytidine 
opposite 80xodG is consistent with the results of the NMR analysis of the 
following two sequences:- 
Sequence A) d[CGC80xoGAATFAGCG] 
Sequence B) d[CGC80xoGAATFCGCG] 
Both sequences are self complementary with sequence A yielding a 
80xodG(syn).dA(anti) pair (Kouchakdjian 1991) and Sequence B a 
80xodG(anti).dC pairing (Oda 1991). These results indicate the presence of 
stable base pairs which are accommodated symmetrically into the duplex with no 
apparent disruption of the phosphodiester backbone. The pairings  established, 
(Figure 1.29), are in complete agreement with the replication experiments of 
Shibitani, and give an accurate explanation as to the reasons for the incorporation 
of dA and dC. The 80xodG(anti).dC pairing observed in sequence B, (Figure 
1.29a), is consistent with a Watson / Crick dC.dG pairing and in this instance is 
not considered a mutagenic lesion, indeed the melting temperature of the 
modified sequence is 44°C, only 3 degrees lower than the native under the same 
conditions (Oda 1991). 
In contrast, the 80xodG(syn).dA(anti) pairing observed in sequence A, (Figure 
1.29b), is similar to the dG(syn).dA mismatch discussed earlier although it would 
be expected to be a much more stable duplex since protonation of the 
deoxyadenosine is not required, thus allowing the formation of a base pair with 
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two hydrogen bonds at physiological pH, resulting in a dG.dC to T.dA 
transversion mutation. Although in the free nucleoside the syn orientation is 
preferred, when helical constraints are placed on the mismatch, the conformation 
adopted will be dependent upon the nature of the opposing base. It is not so easy 
to rationalise the result that chain extension is only observed when a 80xodG.dA 
pair is formed. However from ab-inirio calculations it has been established that 
introduction of an oxygen at the C-8 position influences the entire electrostatic 
potential of the molecule, giving it a negative character (Aida 1987). This will 
undoubtedly have a major effect on the base stacking interactions and in addition 
could drastically alter the DNA / DNA polymerase interaction. It may be that 
80xodG(anti).dC forms a very unusual enzyme / substrate interaction, which 
does not occur with 80xodG(syn), such that the base may not be in a favourable 
base stacking environment. This may be recognised by the proofreading domain 
as a mismatch preventing further synthesis. Variations in polymerase specificity 
between species may account for the differences observed in base incorporation 
opposite the lesion when using different DNA polymerase enzymes. 
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Aims. 
In order to understand fully the potential of modified bases to induce mispairing and hence the 
formation of altered DNA sequences, it is important to understand at a molecular level the way 
in which such bases form mutagenic lesions in duplex DNA. Factors such as base pairing and 
stacking, symmetry of the resultant pair and introduction of new functionalities into the minor 
and major groove are all important in determining whether modifications are tolerated or not. 
Study in this field is extremely important, primarily because DNA mutation, as a result of 
nucleotide modification, is known in many cases to result in the onset of cancers. 
Two modifications of dG, 06MedG and 8oxodG, are known to induce base mispairs which can 
result in insertion of an incorrect amino acid during translation of the gene. The exact 
mechanism for the pairing of 06MedG and 8oxodG is not fully understood and the aim of this 
thesis was to prepare oligonucleotides containing one of the above modified bases and then to 
characterise the base pair mutation by X-ray crystallography and ultraviolet melting. 
Work On 06MedG focused entirely on its effect on duplex DNA since a suitable precursor could 
be purchased, thus allowing its trouble free incorporation into oligonucleotides. A suitable route 
for the synthesis of 8oxodG was not however well established and originally the aim was to 
synthesise a suitable precursor from deoxyguanosine. As a result of some low yielding reactions 
the study was altered to encompass an investigation of some C(8) modified dG nucleosides and 
their stability in DNA. Thus novel functionalities, eg. bromine and -nitrophenylthio, can be 
introduced into DNA at a site which protrudes into either the major or minor groove. Such 
modifications are potentially useful for DNA / protein crosslinking and studying the tolerance of 




The initial stages of chemical carcinogenesis frequently involve the interaction of 
genotoxic agents with DNA to produce covalent modifications in the form of DNA 
adducts (Miller 1981, Searle 1986 and Ames 1979). An important example of this is the 
alkylation of the 06  position of guanine residues in DNA resulting from exposure to 
methylating agents such as N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) (Karran 
1982), methyl methanesuiphonate (MMS) and N-methyl-N-nitrosourea (MNU) 
(Saffhill 1985). The presence of 06MedG constitutes a mutagenic lesion which is 
known to specifically induce G.0 to A.T transition mutations (Loechier 1984) and it 
has been established that proto-oncogenes can be converted to oncogenes by such a 
process (Mitra 1989). Hence the formation of the 06MedG.T base pair during 
replication can give rise to a carcinogenic lesion (Reddy 1982 and Zarbi 1985). In 
recent years the biochemical processes involved in chemically induced carcinogenesis 
have been studied in considerable depth. However, in order to understand further the 
mechanisms of mutagenesis, it is necessary to analyse precisely the molecular details of 
the lesions produced when genotoxic agents interact with DNA. With this overall 
objective in mind, we have determined the structure of such a lesion, the 06MedG.T 
base pair in a B-DNA duplex. 
E Jr 
2.2. Results and discussion 
Ma. d[CGCQñMeGAATFjGCG]. 
1.1b d[CGCñMeGAA1TIGCG]. 
The above oligonucleotides were synthesised using the 06MedG phosphoramidite, 
(Figure 2.1). Synthesis and deprotection are described in the experimental section. After 
synthesis and purification, the above oligonucleotides were subjected to snake venom 
digest analysis to establish the nucleoside composition of the oligonucleotide and to 
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2.2.1. Snake venom digest analysis. 
Enzyme digest analysis allows the base composition of an oligonucleotide to be 
determined by degrading the polymeric chain into its constituent nucleosides. The 










Method 2 digest of 1.1a. 
Figure 2.3b. 
 
Method 1 digest of 1.1a. 
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The separation of a selection of nucleosides, using two reverse phase HPLC techniques, 
can be seen, (Figure 2.2). Although neither system separates all the peaks, the HPLC 
conditions can be optimised depending on the nucleoside composition of the 
oligonucleotide. The main drawback of method 2 is that dG and T are not well resolved 
when dG is in greater concentration, e.g digest of 1.1a. (Figure 2.3a), only elutes as 
four peaks. Method 1 in contrast separates dG and T (difference in retention time of 1 
minute), (Figure 2.3b), thus allowing the base composition of the oligonucleotide to be 
more accurately assigned. Therefore, since the separation of dG and T is important for 
the accurate analysis of the oligonucleotides, method 1 was used. The HPLC traces 
shown, (Figure 2.4), indicate the elution profile of the standards, (Figure 2.4a) with the 









Although only qualitative results were obtained from this work it demonstrated that the 
oligonucleotides were pure, had the correct base composition and that the 06MedG 
residue had survived the conditions of oligonucleotide synthesis and purification. 
2.2.2 HPLC analysis. 
Analysis of the deprotecting dodecamer 1.1a. after 4 days deprotection, revealed two 
very distinct peaks on the elution profile (Figure 2.5a) with retention times of 16.9 mm. 
(peak 1.1a) and 18.4 mm. (peak 1.1a'). 
Figure 2.5a. 
1.1a. Four days deprotection. -WI 
2.Sb. 





1.1a. enzyme digest. 
 
A mixed injection with the native sequence, d[CGC1jAATFGCG],  (Figure 2.5b) 
showed elution of three peaks, with the native oligonucleotide eluting c.a. 2 mm. before 
the modified oligonucleotides, thus confirming that no demethylation of the 0 6MedG 
moiety to dG had occurred. Peaks 1.1a and Ma' were then collected separately, 
reinjected as analytical samples and found to elute as single peaks, thus discounting 
hairpin loop formation or aggregation of the oligonucleotide Ma. confirming that two 
different oligonucleotides were present. 
Figure 2.6a. 
1. la' enzyme digest. 
iJLt 	 011kd~ N1111-1 
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Both samples were then digested with snake venom and by comparing their elution 
profiles with known standards, (Figures 2.6a-c), the identity of the two samples was 
established. Although the peak assigned as 06MedGN(2)th  could not be positively 
identified, because no 06MedGN(2)th  was available, it was later confirmed as this by 
subjecting the two peaks to the oligonucleotide deprotecting conditions for a further 
week, Figures 2.7a and 2.7b. 1.1a still eluted as one component with the same R 1 , 
whereas the profile of Ma' was the same as in Figure 2.5a, indicating that further 
deprotection had taken place. 
The above analysis clearly demonstrated the difficulty in removing the N 2-isobutyryl 
moiety from 06MedG and is consistent with previous reports, (Kuzmich 1983). 
Consequently, a 2 week deprotection strategy was utilised which resulted in a 
deprotected oligonucleotide mixture with a major and minor product ratio of 9:1, 
(Figure 2.8a). Subsequent purification yielded the pure dodecamer as a single peak by 
HPLC, (Figure 2.8b). 
Figure 2.7a. 	 2.7b. 
1. la. after one week further deprotection. 	1. la' after one week further deprotection. 
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Figure 2.8a. 	 2.8b. 
1.1b. after two weeks deprotection. 	 1.1b. after HPLC purification. 
This careful analysis of all oligonucleotides ensured that the samples were not 
contaminated by failure sequences or oligonucleotides containing degraded bases. Thus 
oligonucleotides containing 06MedG, (1.1a. and 1.1b.), were obtained in very high 
purity, which is crucial both for the accurate determination of melting temperatures and 
the formation of high quality crystals necessary for X-ray diffraction studies. 
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2.23. Ultraviolet melting determination. 
The technique of ultraviolet melting relies on the fact that double stranded DNA has a 
lower ultraviolet absorbance than single stranded DNA. Therefore, if the thermal 
denaturation of a self complementary dodecamer is carefully monitored, at 260 nm, a 
rise in the absorbance (ca. 25%) is observed as the duplex denatures to yield single 
strands. Duplexes held together with Watson / Crick bonding denature at higher 
temperatures, d[CGCGAATTCGCG] at Ca. 450C, than similar sequences containing 
base mispairs, d[CGCQMeGAATrGCG] ca.230C. 
2.2.3a. Concentration dependent UV melting. 
According to Equation 1, determining the melting temperature, T m, of a duplex under 
carefully controlled conditions allows thermodynamic parameters to be calculated 
which define the stability of double helical DNA. Q7/o.//zy 1qs7) 
Equation 1. Tm4 = R.lnC I AHO + [AS - ln(1.204).R] / AH4 
Therefore a plot of Tm 1 versus lnC will yield a straight line of gradient R / iH4 which 
bisects the y-axis at [AE1 - ln(l.204).R] / AHO, thus enabling the calculation of AH, 
ASO and AGO. This analysis was carried out on dodecamers 1.1a. and 1.1b. with the 
results, in comparison to the native and other mismatched oligonucleotides, shown in 
Table 3 and Figure 2.9. 
These results indicate that both dodecamers have almost the same duplex stability and. 
therefore the preference of 0 6MedG to pair with T cannot be a result of favourable 
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Table 2.3. 
Thermodynamic Parameters for d[CGCXAATTYGCG]2 duplexes at pH 7.0 in 1.0 M 
NaCl / 10 mM sodium phosphate / 1 mM EDTA. 
Base pair. AH4' kJ.moI 1 ASO J.mol'.K 1 iG1' kJ.mot 1 Tm, K 
dG.dC -430.1 -1164 -83.2 344.6 
dA.T -398.8 -1084.7 -75.7 341.6 
dG.T -331.1 -937.6 -52.3 324.4 
06MedG.dC -213.6 -592.3 -37.2 
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317.1 
06MedG.T -208.4 -577.3 -36.4 315.2 
2.2.3b. pH dependent UV melting. 
Another study was carried out using dodecamers 1.1a. and 1.1b. by monitoring T m as a 
function of pH. Establishing the variation in oligonucleotide stability as a function of 
pH determines whether any protonated or deprotonated base pairs are involved in 
hydrogen bonding. The results from this study are shown in Figure 2.10. 
Before carrying out these pH dependent studies the chemical stability of 06MedG at 
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low pH was determined in the following way: the oligonucleotide 
d[CGCQMeGAATTGCG] was dissolved in 0.1 M phosphate buffer at pH 5.0 and 
after two weeks reversed-phase HPLC analysis showed that there was no significant 
degradation. Mixed injections with the native sequence d[CGCGAATFCGCG], which 
elutes much earlier on reversed-phase HPLC, further confirmed that the 0 6MedG 
containing oligonucleotide had not undergone demethylation. 
Figure 2.10. 
In the above graph, the profile obtained for the two mismatch oligonucleotides, 1.1a 
and 1.1b, have been plotted alongside, the profile of the control sequence, upper curve, 
which illustrates the pH dependent UV melting curve for a standard Watson / Crick 
duplex, which has no variation in stability between pH 5.8 and 8.0. Below pH 6.0 the 
melting temperature drops dramatically, a result of the protonation of dC-N(3) which 
causes destabilisation of the duplex. Although much more unstable than the native 
dodecamer, oligonucleotide 1.1b. exhibits the same trend of pH dependency as the 
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native dodecamer. This is in stark contrast to the curve obtained from oligonucleotide 
1.1a. which demonstrates a variation in stability in the region between pH 5 and 8. The 
curve has a minimum point at pH 6.2 and appears to be a composite of two curves, 
(Figure 2.11.), one which displays a variation in stability, between pH 6.5 and 8, as in 
the native dG.dC sequence, and one which displays a variation in stability between pH 
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The dA.dC mismatch (Hunter 1987), Figure 2.12a, contained in the dodedecamer 
dCGCAAATFGCG, forms a wobble pair with two hydrogen bonds, one of which 
requires protonation of dA-N(1). The duplex is very unstable at pH 7.7 because it is 
unable to exist in the non-protonated form, and as a result the duplex cannot maintain a 
double helical structure. At lower pH, N(1) protonation becomes possible such that two 
hydrogen bonds can form, and so the stability of the duplex increases to a maximum at 




indicates the existence of a protonated and a non-protonated base pair. In basic 
conditions the curve parallels that of the dG.dC dodecamer implying a non-protonated 
base pair as in Figure 2.12b. At acidic pH however, a minimum point is reached (at pH 
6.2) where the curve then begins to parallel that of the dA.dC dodecamer, reaching a 
maximum at pH 5.6. This is due to the protonation of dC-N(3) of the mispair, resulting 
in the pairing shown in Figure 2.12c. Since both pairings have equal stability it is 
reasonable to assume that in an in vivo environment an 06MedG.dC  pairing will exist 
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2.2.4. Crystal structure of d[CGCQñMeGAATTIGCG]2 
The X-ray structure analysis of the self-complementary dodecanucleotide 
d[CGCQñMeGAATTIGCG]2 shows that in overall shape the O6MedG.T  mispair is 
remarkably similar to a Watson I Crick base pair. The bases are directly opposite each 
other, the glycosyl linkages are related by a pseudodyad, and in the minor groove the 
base pair is indistinguishable from a dG.dC base pair. Overall, there are very few 
structural differences between the O6MedG.T  duplex and the well-studied native one, 
d[CGC1jAATTGCG]2 (Wing 1980). The helical parameters, torsion angles and 
hydration pattern are almost identical and the presence of the mutagenic base pair does 
not distort the sugar-phosphate backbone. Despite these considerable similarities, 
ultraviolet melting studies indicate that the O6MedG.T  duplex is much less stable than 
the native dG.dC duplex (MG4 46.8 KJ.mole-l), (Table 2.3). Hence the O6M edG.T 
base pair has a powerful destabilising effect in B-DNA. 
The two O6MedG.T  base pairs in the dodecamer duplex are essentially identical and the 
2F.-F, map of the 06MedG(9).T(16) pair is shown in Figure 2.13, overleaf. There are 
three close contacts between the O6MedG and T bases; one of 2.9A from purine-06 to 
pyrimidine-04, a second of 2.9A from purine-N(1) to pyrimidine-N(3), and a third of 
2.8A between jurine-N2 and pyrimidine-02. At this resolution hydrogen atoms were 
not observed and the most likely base pair is shown in Figure 2.14, with each base in its 
most common tautomer. 
Figure 2.14. 
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There is unlikely to be a hydrogen bond between 06-purine and 0 4-pyrimidine, as 
neither has an attached hydrogen and neither functional group is sufficiently basic to be 
protonated at pH 6.3. In addition, there is no evidence in the pH-dependent ultraviolet 
melting profile of the duplex (Figure 2.10) for a protonatéd base pair. Hence, formation 
of the double strand from the fully hydrated single strands will lead to the loss of a 
hydrogen bond between each of these oxygen atoms and neighbouring solvent 
molecules. As these are not replaced by inter-base hydrogen bonds, the effect will be to 
destabilise the duplex. The interaction between purine-06 and pyrimidine-04 will be 
destabilising for the additional reason that the two electronegative oxygen atoms are 
forced together by the two adjacent strong hydrogen bonds in the base pair (Nagata 
1988), one from pyrimidine-N(3) to purine-N(1) and a second from purine-N2 to 
pyrimidine-02. It is possible to postulate other forms of the OóMedG.T base pair by 
invoking minor tautomers but there is no direct experimental evidence for their 
existence. The base pair in Figure 2.14 has two hydrogen bonds which are adjacent to 
each other and the resultant co-operativity allows the formation of a stable base pair. 
The 06MedG.T base pairing found in the present X-ray structure is identical to that 
postulated from molecular orbital and molecular mechanical calculations, and from an 
nmr study of a mixture of the 06MedG and thymidine nucleosides in chloroform 
solution (Williams 1987). However it differs in important details from that proposed in 
an oligonucleotide nuclear magnetic resonance study, although interpretation of the 
spectra was limited by the lack of direct information on the relative orientation of the 
two bases, (Patel 1988). 
The most striking differences between the 06MedG.T mispair and a dG.dC base pair 
are in the major groove, owing to the presence of the methyl group attached to the 
purine 06-atom, located proximal to the N(7)-atom in the plane of the purine ring 
(Figure 2.15). This will give rise to steric repulsion between the guanine base and the 
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attached methyl group: Although the distal conformation is preferred in the free 
nucleoside (Parthasarathay 1986 and Yamagata 1988), it is likely to be very unstable in 
the 06MedG.T base pair (Pedersen 1988) as it will prevent the formation of inter-base 
hydrogen bonds. In the proximal orientation the methyl group presents a steric barrier 
to any regulatory or repair enzyme that might otherwise interact with the guanine 06-
or N(7)-atom. The appearance of the 06MedG.T  base pair in the major groove is. 
different from that of a Watson / Crick dA.T or dG.dC base pair in two additional 
details: i) there are two methyl groups, one attached to each base, and ii) there is no 
hetero-atom with a capacity to donate hydrogen bonds. 
2.2.5. Conclusion. 
When a guanine base in genomic DNA is converted to 06MedG by a chemical 
mutagen, the modified base normally codes for thymine instead of cytosine (Snow 
1984), resulting in an in vivo mutation frequency of between 15% (Chambers 1985) and 
75% (Bhanot 1986). The in vitro misinsertion frequency is more than 95% (Toorchen 
1983) and the only efficient form of repair involves demethylation of the 06-atom of 
guanine by the enzyme 06-methyl guanine methyl transferase to regenerate guanine 
(Olsson 1980 and Demple 1982). Thus, the 06MedG.T  base pair is recognised as being 
more similar to a Watson / Crick base pair than is the 06MedG.dC base pair. The 
reasons for this are unlikely to be thermodynamic in origin (Gaffney 1984 and 1989), as 
ultraviolet melting studies show that the duplex containing the 06MedG.T base pair is 
slightly less stable than the corresponding 06MedG.dC  duplex at neutral pH (&G4 0.8 
KJ.mole-l) (Table 2.3). Moreover, the 06MedG.T  duplex is less stable than the duplex 
containing the dG.T wobble base pair mismatch which is rarely incorporated during 
replication owing to efficient proofreading (MG4' 15.9 KJ.mole-i). 
The incorporation of the 06MedG.T base pair in preference to the 06MedG.dC  base 
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pair in genomic DNA can be rationalised in structural terms. The similarity in shape 
between the 06MedG.T mispair and a Watson I Crick base pair, particularly in the 
minor groove is striking, whereas the 06MedG.dC base pair has been postulated on the 
basis of theoretical and nuclear magnetic resonance studies to be a reverse wobble base 
pair as in Figure 2.12b (Patel 1986 and Pedersen 1988). This would, by analogy with 
mismatch base pairs, be removed by proofreading. Thus the enzymes in the cell nucleus 
responsible for DNA synthesis and repair discriminate in favour of the mutagenic 
lesion. We have studied the stability profile of the DNA duplex containing the 
06MedG.dC base pair over a wide pH range (Figure 2.10) and have observed that the 
o, qosi 
melting temperature falls slightlfrom pH 8.5 to pH 6.5, as would be expected for the 
unprotonated wobble base pair 2.12b. At lower pH however, there is a clear indication 
of duplex stabilisation, probably due to protonation of cytosine-N3 of the mispair, 
which would lead to the formation of a Watson / Crick-like base pair, a resonance form 
of which is shown in Figure 2.12c. Thus, the 06MedG.dC base pair displays 
conformational flexibility. The protonated base pair 2.12c, which is probably present to 
some extent at neutral pH, would be expected on structural grounds to be incorporated 
during replication. Such a base pair has been identified in a nuclear magnetic resonance 
study of a mixture of the nucleosides in non-aqueous solvents (Williams 1987) and in 
the X-ray structure of a Z-DNA duplex (Ginell 1990). The occasional occurrence of 
2.12c might explain why the presence of 06MedG in genomic DNA does not always 




8-Oxo-7-hydro-2'-deoxyguanosine, (80xodG), is a product of oxidative damage to 
DNA and can cause base mispairing during replicative events. The potential for 
80xodG to pair with either dC or dA is of great interest, since, asolined in the 
introduction, (Figure 1.29.), pairing with dC has been shown in certain polymerase 
systems to halt replication, (Shibutani 1991), whereas pairing with dA would 
constitute a mutagenic lesion. In an effort to establish the base pairings possible with 
80xodG we have attempted its synthesis by a variety of methods utilising C(8)-
modified dG derivatives both in the nucleoside form and on its incorporation into 
oligonucleotides. 
8-Bromo-2'-deoxyguanosine(8BrdG), is a very important intermediate in the 
synthesis of C(8)-dG derivatives since the presence of a bromine atom activates the 
C(8) position to nucleophilic attack and consequently enables the introduction of an 
alternative functionality, eg. methoxy or benzyloxy.(It has been established from 
electron density calculations that the C(8) position of dG is the most susceptible to 
electrophilic and free radical attack, (Holmes 1964), thus facilitating the 
bromination. 8BrdG can be utilised as the starting material for two possible routes 
towards the synthesis of 80xodG, (Figure 3.1). Route A involves displacement of the 
bromine atom by methoxide anion, (Tai-Shun Lin 1985), to produce 8-methoxy-2'-
deoxyguanosine (8MeOdG). The last reaction in this route was thought to be 
possible as a result of the work by Kuchino, (Kuchino 1987), who demonstrated that 
oligonucleotides containing 8MeOdG could be converted to their 80xo derivatives 
by the action of DMIF / TEA / water. 
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The alternative method, Route B, involves displacement of the bromine with 
benzyloxide anion. The resultant 8-benxyloxy-2'-deoxyguanosine(8BnOclG) can be 
easily transformed into the 80xo derivative via hydrogenation. (rAi SHoii, 13c) 
Thus, two alternative approaches exist, one which leads to the insertion of a 
protected 80xodG (Route A, Sect. 3.2.) and the other an unprotected 80xodG 
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3.2. Conversion of 8MeOdG to 80xodG. 
(B t'aL-) 
The crude product, 3, was obtained as a pale yellow powder in approximately 80% 
yield and was used for subsequent reactions without further purification since all 
attempts at purification by crystallisation were unsuccessful despite reports to the 
contrary, (Tai-Shun Lin 1985). All attempts to repeat this work, and in alternative 
solvents, resulted in the formation of a very thick gel on cooling but no crystals. 
Analysis, (t.l.c. and HPLC), indicated no major impurities in the crude powder and it 
was therefore used in this form. 
At no point was it possible to convert 8MeOdG to 80xodG using the DMF I TEA I 
Water system reported by Kuchino, (Kuchino 1987). This reaction was also carried 
out on oligonucleotides containing an 8MeOdG base, where the pKa value of the 
N(1) proton is slightly higher, (Saenger 1984), but no reaction was observed, see 
section 3.2.3. 
During an attempt to recrystallise 8MeOdG from a solution of pyridine / water (1:1) 
it was noticed that the sample had degraded into two distinct components (HPLC and 
t.l.c.) in equal quantities. Separation of the two components by HPLC, method 2, 
followed by UV analysis indicated that one component was 8MeOdG, (Tai-Shun Lin 
1985) and the other 80xodG, (Figure 3.2a), (Culp 1989). The presence of 80xodG 
was further confirmed by co-elution, against standard 80xodG, (HPLC, method 3.), 
(Figure 3.2b). CompootL 2,, $- lolls - 
Although the initial conversion in pyridine / water was not particularly high yielding, 
it was found that addition of TEA and DBU to the reaction mixture enhanced the 
conversion to nearly 100%, as determined analytically by HPLC and t.1.c. The use of 
thiophenol was also found to be beneficial to this transformation with the addition of 
TEA and DBU again enhancing the conversion to nearly 100%, (HPLC profiles 
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Although it was clear from this work on the free nucleoside, that 80xodG could be 
S(2. P 11 
readily produced from 8MeOd, a major problem was again the purification of the 
C(8)- alkoxy and oxo products. As a result it was decided to proceed with the 
incorporation of 8MeOdG into oligonucleotides and to carry out conversion after 
oligonucleotide synthesis was complete. This also had the advantage of allowing us 
to utilise the capacity of the synthesiser to deliver a solution of thiophenol / dioxan / 
TEA (20:78:2), to the column containing the oligonucleotide. This also simplifies 
purification, since excess thiophenol can be easily washed of the column using dry 
MOO 
Figure 3.3. 
a).PyridinefMethanolfrhiophenol.(S6IUL :o' 	b). A + water. 












methanol. With this aim in mind, the synthesis of a suitable phosphoramidite 
monomer was achieved, and 8MeOdG subsequently incorporated into an 
oligonucleotide. 
3.2.1. Synthesis of an 8MeOdG monomer. 
1 ' 
Incorporation of 8MeOdG into oligonucleotides necessitated the synthesis of 
nucleoside monomer S. (Figure 3.4), which could be inserted into an oligonucleotide 
via the phosphoramidite strategy of DNA synthesis (Beaucage 1992). 
Figure 3.4. 
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Having obtained compound 3. in suitable quantity the requisite N2 3'0- and 5'O-
protecting groups were then attached. 
The N2  amino group of 8MeOdG was selectively protected by reaction of 3. with 
dimethylformamide diethyl acetal to afford the N 2-methylene-dimethylamine 
derivative. With no purification, this was reacted with 4,4'-dimethoxytrityl chloride, 
which, in the presence of DMAP, reacts specifically on the primary 5'-hydroxyl 
moiety yielding compound 4., which exits as a mixture of cis and trans isomers. 
These isomers were easily visualised by t.l.c. and were shown to have identicai 
chemical composition by FAB-MS. In addition, reaction of 4. with NH 3 
removes the N2  protection leading to the formation of only one trityl positive 
component at lower Rf. Reaction of compound 4. with mCPA afforded the suitable 
phosphoramidite nucleotide derivative, 5., which was incorporated into 
oligonucleotides 6.1 and 6.2. with a coupling efficiency of> 99%. The synthesis of 
this oligonucleotide therefore allowed a direct comparison to be drawn between 
formation of 80xodG from 8MeOdG nucleosides, section 3.2. and from 8MeOdG 
incorporated into DNA. 
3.2.2 Oligonucleotides containing 8MeOdG. 
Oligonucleotides 6.1. and 6.2., see below, were synthesised as several 0.2 pM 
preparations and were subjected to the various reaction conditions found to promote 
the conversion of 8MeOdG to 80xodG, section 3.2. 
6.1. d[CCCCC8MeOGTCCCCC] 
6.2. Same sequence as 6.1. but was retained on the CPG beads in its protected form. 
Reactions were carried out by injecting the reagents into the column. 
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After exposure to various reaction conditions, eg. DBU I TEA / Water, Thiophenol I 
DBU and Thiophenol / TEA, the oligonucleotides were examined by HPLC and their 
retention times compared to a control sample of 6.1. which had been purified as 
outlined in the experimental section. In the case of reactions involving 
oligonucleotide 6.2. it was first of all necessary to deprotect and purify the sequence. 
This was carried out using the standard conditions described in the experimental 
section. This particular sequence was used since it is much easier to purify 
dodecamers, by gel filtration, than shorter sequences and also because the elution, on 
HPLC, of dC and T is earlier than 8MeOdG or 80xodG. 
Basic conditions 	used for promoting the conversion of 8MeOdG to 80xodG so it 
was necessary to establish that degradation of 8MeOdG would not result from the hot 
conc. NH3  solution which is required for deprotection of the oligonucleotide. No 
degradation was observed on incubating both 8MeOdG and oligonucleotide 6.1. in a 
solution of conc. NH3 at 60°C over a 24 hour period. 
Unfortunately none of the conditions used, ie. thiophenol / TEA or DBU and DMF / 
TEA / Water, showed any signs of converting 8MeOdG to 80xodG, (Figures 3.5a 
and 3.5b). However, it was possible that oligonucleotides containing 80xodG and 
8MeOdG were co-eluting, and in order to establish whether or not any reaction had 
taken place it was necessary to subject the product oligonucleotides to enzyme digest 
and HPLC analysis such that the nature of the component nucleosides could be 
confirmed. Comparison of the elution profile of these digested samples against base 
standards indicated that all of the reaction conditions yielded an oligonucleotide 
containing the three components dC, T and 8MeOdG. This is clearly illustrated in 
Figures 3.5c and 3.5d. 
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Figure 3.5. 
A) Elution profile of 6.1. 
t2t i'ii,. 
B) Mixed injection. 6.1. control and after reaction with DBU, TEA and water. 
71 
Figure 3.5. 
C) Enzyme digest profile of 6.1. after reaction with DBU, thiophenol and water. 
ai- mn. 
.J ef7Zyrfle. 49e5 
D) Mixed injection of 	with base standards, dC (8.8 mm.), T (12.1 mm.) and 8MeOdG (18 mm.). 
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It is not clear why an 8MeOdG base contained in an oligonucleotide could not be 
converted into an 80xodG residue. It is possible that the mode of action of 
thiophenol, in comparison to the same reaction at the nucleoside level, (Figure 3.6), 
is affected by the slightly higher pKa values of the ring nitrogens in the 5' and 3' 
phosphorylated nucleoside. 
Figure 3.6. 
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Conversion of oligonucleotides containing 8MeOdG to those containing 80xodG 
was subsequently demonstrated, (0th 1991), using a solution comprising thiophenol, 
TEA and DMF. Their choice of protection for the N2 position of 8MeOdG was 
different from ours and our negative results may be a result of the slightly poorer 
electron withdrawing properties of the methylene-dimethylamine functionality in 
comparison to an amide moiety. The presence of an amide group might enhance the 
lability of the C-8 ether linkage to nucleophilic attack by lowering the 
electronegativity of the purine ring, the amidine group however, being less electron 
withdrawing, will not have same effect and will suppress nucleophilic displacement 
of the C(8)- Br. This would also explain the lack of reactivity of the unprotected 
oligoncleotide, 6.1. 
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As a result of this lack of success in converting 8MeOdG to 80xodG it was decided 
to investigate the alternative, Route B in Figure 3.1., involving the direct 
incorporation of 80xodG into an oligonucleotide. 
33. Synthesis of 8-BnodG nucleosides. 
The synthesis of 8-benzyloxy-2'-deoxyguanosine (8BnOdG) 7., has been well 
documented and was straightforward, (Figure 3.7.). (rsi -5 Mo&, 1ef5,). 
Figure 3.7. 
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However, for the same reasons as for 8MeOdG, it was not possible to purify 7. by 
crystallisation. Recrystallisation from methanol leads to only a 28% recovery, (Tai-
Shun Lin 1985), so it was decided to convert 7. to the triisobutyryl derivative, 
allowing purification of 8. by silica gel chromatography, with subsequent 
hydrogenation yielding compound 9. 
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However, due to the difficulty in producing large amounts of compound 7. in a pure 
form, it was decided to use protected forms of 8BrdG to yield the 8-alkoxy 
derivatives. This would simplify the purification problem by rendering the products 
soluble in organic solvents, thus allowing the use of silica gel chromatography for 
purification at each stage of the synthesis. This would prevent impurities from one 
reaction being carried over into the next, a likely cause of the poor yields. 
3.4. Reactions of 8BrdG. 
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hydroxyl groups followed by attachment of an isobutyryl or phenylacetyl group 
yielded compounds 11.1. and 11.2. respectively. Subsequent saponification of the 
ester moieties followed by reaction with 4,4'-dimetho'xythtyl-chloride afforded 12. 
Reaction of 12. with sodium hydroxide, benzyloxide or methoxide yielded only 
compound 13. which was formed by simple cleavage of the base labile N 2 amide 
functionality. No displacement of the bromine was observed, (confirmed by FAB-
MS: peaks at 416 and 418, in a 1:1 ratio). Therefore compound 14. was prepared, 
(Figure 3.9.), which contains an N2 acid labile dlimethoxytrityl group. 
Figure 3.9. 
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Attempts to displace bromine from this compound with hydroxide, methoxide and 
benzyloxide, with and without DMSO present, all proved unsuccessful with 
compound 14. being extremely stable under all these conditions. 
The lack of displacement of bromine from compounds 12. and 14. can be attributed 
to two effects, the large steric bulk of the dimethoxytrityl moiety and its net electron 
donating properties when attached to the N 2 position where it can directly interact 
with the purine ring resonance. This explains why 8BrdG derivatives, 12. and 14., 
remain inactive to attack by the three anions, hydroxide, methoxide and benzyloxide, 
whereas the bromine atom of the unprotected nucleoside, compound 2., can be 
readily displaced by both methoxide and benzyloxide. 
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3.4.1. Reaction of 8BrdG with hydroxide. 
A method for the preparation of alcohols is via the hydrolysis of the corresponding 
halogeno compound using sodium or potassium hydroxide (Morrison and Boyd). If it 
was possible to hydrolyse the C(8)-Br bond of 8BrdG, then it would react to form 8-
hydroxydG which would rapidly tautomerise to the predominant 8-keto-7-hydro 
form, (80xodG), (Figure 3.10.). Reaction of 2. at 60°C showed no displacement of 
the bromine by hydroxide, and this can be readily explained by the very high pH of 
the reaction mixture. A strong base, rather than hydrolysing the C(8)-Br bond, will 














8BrdG has an N(1) proton with a pKa of 9.42 (Saenger 1984), therefore, when using 
strong bases such as sodium and potassium hydroxide the N(1) proton will be 
immediately abstracted resulting in an anionic purine ring. This will have the effect 
of inactivating the ring to substitution by nucleophiic reagents. Such inactivation has 
been well documented in the reaction of trichloropurine with hydroxide ions, (Figure 
3.11a). If however the deprotonation at N(9) is prevented, by the attachment of a 
tetrahydro-2'-pyranyl group, (Figure 3.11b), then hydrolysis of the C(8)-Cl bond is 
observed, yielding the 8-hydroxy derivative (Suttcliffe 1963). 
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Figure 3.11. 
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For the same reasons, reaction of 8BrdG with strong base will not readily promote 
hydrolysis of the C(8)-Br bond since the N(1) position will be deprotonated, (Figure 
3.12.). 
Figure 3.12. 
0 	 0H 	 0 
 NfBr 	
N 
dR 	 dR 
In order to assess the potential for bromine displacement, various nucleophiles, eg. 
azide, benzene suiphinic acid and various thiols, which can be activated by bases 
such as TEA, DBU and pyridine, were reacted with either compound 2. or 10. 
Acetate was also used as a nucleophile since it has been demonstrated (Guy 1988) 
that the treatment of 813rdA with NaOAc in the presence of AcOH or Ac 20 leads to 
bromine displacement to afford the acetylated 8-Oxo derivative. This is not however 
a viable route to 80xodG due to extensive depurination during the reaction. Indeed 
when this was examined, (Roelen 1991) it was found to result in a yield of 5', 3', N2- 
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triacetyl-80xodG of only 12%. 8-Oxo-7-hydro-guanosine can be readily prepared by 
this method since the depurination problems are less severe when dealing with 
ribosides as opposed to deoxyribosides, (Roelen 1991). 
Only one nucleophile, -nitrothiophenoi, was found io displace bromine, and the 
reaction was carried out in pyridine at room temperature on compounds 11.1. and 
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R = Isobutyryl, 11.1. and 15.1. 	R = Phenylacetyl, 11.2. and 15.2. 
No other sulphur containing nucleophiles were found to displace the bromine and it 
was decided to incorporate 8BrdG into oligonucleotides to establish whether or not 
this would improve the lability of the C(8)-Br bond. 
3.5. Incorporation of 8BrdG into oligonucleotides. 
Synthesis of the 8BrdG phosphoramidite, 16., was carried out in accordance with the 
general procedure outlined by Gait,(&& 1984). Reaction of 10. with isobutyryl 
chloride afforded 11.1. which was saponified with NaOH and reacted with 4,4'-
dimethoxytrityl chloride to give 12., (Figure 3.8). Phosphitilation of the 3'-hydroxyl 
group then yielded the desired phosphoramidite 16., (Figure 3.14), which was 
incorporated, with 98.3% coupling efficiency, into oligonucleotides 17. and 18a-e. 




























3.5.1. Reaction of d[TT8DjjTT]  with nucleophilic reagents. 
In order to fully assess the possibilities of displacing the bromine of 8BrdG with 
nucleophilic reagents, oligonucleotide 20., d[TT8BrGTT], was synthesised and 
subjected to various reagents. In all cases no displacement of bromine was observed. 
The product oligonucleotides all coeluted with the control oligonucleotide, 
d[TT8BrGTT], and HPLC analysis of the enzyme digest indicated only two 
components, T and 8BrdG, (Figures 3.15a and 3.15b). 
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Figure 3.15. 
A) Mixed injection, enzyme digest of 20., after reaction with -nitrothiopheno1, and standard 
8BrdG + T. 
Rt = 11.7 mm. (T), Rt = 17.1 mm. (8BrdG). 
ti- mii. 
B) Standard 8BrdG and T. 
- 
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3.6. Displacement of bromine with u-nitrothiophenol. 
As outlined in Figure 3.14., successful displacement of the bromine was achieved 
using g-nitrothiophenol, to generate compounds 15.1. and 15.2., which was very 
important since it has been shown (Nikiforov 1991) that in certain cases - 
nitrophenylthio, (NPT), can be displaced using potassiumthioacetate to generate the 
thiol derivative. Furthermore, it has also been shown that conc. ammonia can be used 
to displace the -nitrophenylthiol moiety to generate the keto derivative. Both these 
reactions were of great interest since both 8-oxo and 8-thio derivatives were 
potentially very useful. No substitutions were observed in our case however and 
disappointingly the 8NPTdG derivative was extremely stable to all conditions tested. 
It may be that severe steric crowding around the C(8) position makes these otherwise 
standard reactions very difficult due to the close proximity of the sugar moiety 
preventing attack from nucleophiles. Oxidation of the sulphur with mercuric chloride 
and iodine proved unsuccessful. 
As a result of the stability of the compound to the reagents described above and also 
to hot conc. NH3 , it was a good candidate for incorporation into oligonucleotides 
where the presence of the C(8)-NPT moiety could perhaps be utilised for the binding 
of antibodies. A highly selective method whereby a specific functionality is bound 
by an antibody, after first of all creating an immune response, (Catty 1988). Before 
considering this method however, it is necessary to establish the effect of such a 
group upon the stability of the duplex. This can be determined by ultraviolet melting. 
In addition, it was necessary to establish whether or not the NPT functionality could 
be displaced by NH3  or thioacetate when 8NPTdG was incorporated into an 
oligonucleotide. The synthesis of a suitable 8NPTdG phosphoramidite was carried 
out as illustrated in (Figure 3.16.). The phosphoramidite 21. could have been 
synthesised using N2-isobutyryl or N2-phenylacetyl protection, but only the 
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isobutyryl derivative, 15.1. was prepared which was suitably protected to yield 
monomer 21. This was successfully introduced into oligonucleotides 22.a-d., see 
experimental section 4.3., with a coupling efficiency of 99.7%. No displacement of 























3.7. Thermodynamic stability of dodecamers containing C(8)- Br and NV!' 
substituted dG. 
Oligonucleotides 18a - e. and 22a - d. were examined by UV melting techniques 
such that the melting temperature, T m, could be established enabling the effect of the 
substituents on the duplex stability to be assessed. 
The melting temperatures, (Table 3. 1), demonstrate the destabilisation of the duplex 
that occurs when either bromine or -nitrophenylthio are incorporated at the C-8 
position of dG. The presence of two 8NPTdG.dC base pairs, the most stable base 
pair in this series of oligonucleotides, resulted in an oligonucleoticle with a T m which 
was 28.20K lower than that for the native dG.dC oligonucleotide. 
Table 3.1. 
Oligonucleotide. TmOK. 
d[CGCQAATTGCG] T 338.2 
X=8BrdG. X=8NPTdG. 
d[CGCXAArFAGCG] 283.2 (Vd) 
d[CGCXAATTIiGCG] 322 (1) 304.2 C ZZo.) 
d{CGCXAATTGCGI 330 C".) 310 (2L) 
d[CGCXAATTIGCG] 310.8 (i&) 283.4 (22,r_) 
d[CGCAAATTXGCG] 301.5 296.1 (2U) 
All other base pairs containing 8NPTdG, yielded duplexes of extremely low stability. 
This can possibly be attributed to the bulkiness of the group which creates severe 
steric hindrance and inhibits duplex formation. As a consequence of this unstable 
duplex, 8NPTdG is unsuitable for incorporation into oligonucleotides since there is 
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severe disruption of the normal pairing and stacking interactions necessary for 
formation of stable helical DNA. 
When 8BrdG was incorporated into oligonucleotides the resultant destabilisation was 
much less dramatic, indicating the ability of the duplex to accommodate the bromine 
atom. Oligonucleotides 18b. and 18c. are the most stable of the series with T m  values 
16.2 and 8.20K less than the native dG.dC dodecamer. 
Although this work does not yield any direct evidence on the pairing of 8BrdG with 
the four naturally occuring nucleotides, it does however demonstrate that the 
incorporation of a C(8)- bromine substituent will not drastically alter the base pairing 
properties, and the ability of the oligonucleotide to form a nearly normal helix. The 
presence of such C(8) substitutions can have the effect of altering the base into a syn 
orientation, (Uesugi 1977), and although it is not possible to establish whether or not 
this occurs in the above sequences, this effect may have consequences when 8BrdG 
is incorporated into dG rich sequences. 
Oligonucleotides containing dG rich regions are notoriously difficult to purify due to 
unfavourable secondary structure formation. Secondary structures involving dG are 
well known to occur in telomeric regions, dG rich regions at the end of 
chromosomes, which help to seal the chromosome and prevent fraying of the ends 
(Chul-Hee 1992). The structure of telomeres are known to involve dG tetrads which 
utilise both the Hoogsteen and Watson / Crick hydrogen bonding sites and rely on 
alternate dG's adopting a syn orientation. As a result, it was decided to incorporate 
8BrdG into such sequences at every alternate dG in the dG rich region to determine 
whether or not the presence of such a base would interfere and destabilise these 
undesirable structures. Its incorporation did not however prevent the formation of 
these secondary strucure and as a result did not resolve the purification problems, 
indicating that 8BrdG was probably accommodated into the duplex in the same 
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manner as dG. For another reason however, this has proved to be an extremely 
beneficial property since the presence of a bromine atom, with its high electron 
density, can be used as a heavy atom marker in aiding the refinement of 
oligonucleotide X-ray crystallographic data. 
Difficulty in solving the crystal structure of a d[TGTACA] / nogalomycin complex, 
has highlighted the need for the incorporation of a nucleotide containing a heavy 
atom marker. As such, 8BrdG was used to replaced dG in the above sequence and the 
resultant d[T8BrGTACA] / nogalomycin complex was crystallised in the same space 
group as the native complex, further demonstrating that the C(8)-Br does not unduly 
interfere with formation of the helix. Thus the X-ray data, for the complex 
containing 8BrdG, which has been collected to 2.5 A, can be used to aid the structure 
solution. 
3.8. Conclusion. 
Incorporation of 8MeOdG into oligonucleotides was carried Out very successfully, 
although synthesis of the 8oxo derivative was not possible. 80xodG has however 
been utilised in oligonucleotides, (Kouchakdjian 1991 and Oda 1991). Kouchakdjian 
synthesised an 80xodG phosphoramidite via the 8-benzyloxy intermediate which 
was readily hydrogenated to 80xodG. The methodology adopted by Oda was to 
synthesise oligonucleotides containing an 8MeOdG nucleotide containing acetyl 
protection on the N2  amine. The methoxy moiety was then converted into the oxo 
derivative by action of thiophenol prior to deprotection of the oligonucleotide. Our 
oligonucleotides contained 8MeOdG nucleotides with dimethylaminomethylene 
protection on the N2  amine. By using this form of protecting group it allowed us to 
selectively protect the N2 amine and react the product with dimethoxytrityl chloride 
without purification of the intermediate. In contrast, amide protection, eg. isobutyryl, 
yields the 5', 3'-(0)-N2- tris isobutyryl derivative which requires removal of the ester 
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moieties, prior to reaction with dimethoxytrityichioricle, and we found this extremely 
problematical when using both acetyl and isobutyryl as the amide protection. 
Recent work however, (Bodepudi 1992), has indicated the best method for synthesis 
of an 80xodG nucleoside. The work described has significantly improved the yields 
of 8BrdG and 8BnOdG to 84%, previously 55%, and 70%, previously 28%, 
respectively. Protection of the amine with the isobutyryl moiety followed, by 
hydrogenation yielded the desired 8-oxo derivative which was easily transformed 
into the corresponding nucleoside phosphoramidite and incorporated into DNA with 
a > 98% coupling efficiency. 
Another alternative, for more diverse C(8) modification, would involve the synthesis 
of an 06 protected 8BrdG. This form of protection would have the effect of 
deprotonating the N(l) position thus allowing more facile displacement of the 
bromine in basic conditions. It is conceivable that a suitable group, such as 
mesitylene suiphonyl, (Li 1989), or 4-nitrophenethyl, (Gaffney 1982), would be 
sufficiently stable to enable displacement of the bromine by anions such as azide, 
acetate or hydroxide allowing the synthesis of a variety of C(8) substituted dO 
derivatives. Such substituted nucleotides would find use in areas such as DNA / 
protein crosslinking, protein / DNA recognition and in the study of mismatched base 
pairs. 
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4. Experimental section. 
4.1. Organic solvents. 
DNA synthesis grade acetonitrile and all other reagents required for the synthesis of 
oligonucleotides were purchased from Applied Biosystems Ltd. HPLC grade 
acetonitrile was purchased from Fisons and anhydrous dimethylformamide (HPLC 
grade) was purchased from Aldrich. 
Purification of organic solvents. 
Methanol was dried by distillation from magnesium turnings and iodine; 
Dichioromethane and Pyridine were dried by distillation from CaB 2. Dimethyl 
suiphoxide was dried by stirring overnight with CaR 2 followed by distillation under 
reduced pressure (b.pt. 76°C / 1.6 x 103  Nm 2). Tetrahydrofuran was dried by 
distillation from sodium benzophenone. Benzyl alcohol was purified by distillation 
under reduced pressure (b.pt. 65°C I 750 Nm 2). Diethyl ether and toluene were 
dried by addition of sodium wire. N,N'-diisopropylethylamine was dried by storage 
over CaH2 . 
4.2 Exrerimental Techniques. 
4.2.1. Thin layer chromatography (t.l.c.). 
All t.l.c. analysis was carried out using Merck aluminium sheets coated with silica 
gel 60 F254. After elution, the chromatograms were examined under ultraviolet light. 
For use with molecules containing the acid labile 4,4'-dimethoxytrityl moiety, the 
silica plates were soaked in triethylamine and dried prior to use. Visualisation of 
components present on the tic. plate was carried out using the reagents described 
below. 
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Visualisation of t.I.c. chromatograms. 
Presence of sugars: A solution comprising anisaldehyde (5 ml), acetic acid (1 ml), 
sulphuric acid (1 ml) and ethanol (100 ml), was sprayed onto the t.l.c. plate which 
was then heated on a hotplate. A positive test was indicated by a blue / green 
colouration on heating. This test also allowed positive identification of compounds 
containing the 4,4'-dimethoxytrityl group due to the production of an orange colour 
immediately upon spraying. 
Presence of the 4,4'-dimethoxytrityl moiety: Holding the t.l.c. plate over a beaker 
of conc. hydrochloric acid produced an intense orange colour 
Presence of the 2-cyanoethyl-N,N'-diisopropyl-phosphoramidjte moiety: A 0.1% 
solution of dithio-bis -nitrobenzoic acid in ethanol / Tris buffer (0.45 M, pH 8.2), 1 
1, (Bilmans reagent), was sprayed onto the t.l.c. plate to produce an instantaneous 
bright yellow colour. 
Solvent systems for t.l.c. (all v/v). 
Dichloromethane (4), methanol (1), acetic acid (10 drops). 
Dichioromethane (6), methanol (1), acetic acid (10 drops). 
Dichloromethane (9), methanol (1), acetic acid (10 drops). 
Dichloromethane (4), methanol (1). 
Dichioromethane (7), methanol (1). 
Dichloromethane (9), methanol (1). 
Dichioromethane (95), methanol (5). 
n-Butanol (3), water (1), acetic acid (10 drops). 
i-Propanol (3), water (1), ammonia (10 drops). 
Ethanol (8), water (2). 
Ethylacetate (5), dichioromethane (5). 
Ethylacetate (8), dichioromethane (2), TEA (10 drops). 
Dichloromethane (95), methanol (5), TEA (10 drops). 
Acetonitrile (95), ethylacetate (5) and TEA (10 drops). 
0. Acetonitrile (2 ), dichioromethane (8 ). 
4.2.2. Oligonucleotide crystallisations. 
The oligonucleotide (0.9 mg) was dissolved in sodium cacodylate (50 mM, 45 p.1, pH 
7.0) and 5 p.l of this solution was placed into the first well of a nine well crystallising 
plate. Specific quantities of solutions A, B and C were then added sequentially, (see 
below), in that order, ensuring that the oligonucleotide did not precipitate. 
Solution A: MgCl2  (100 mM). 
Solution B: 50% aqueous 2.-methyl-2,4-pentanediol. 
Solution C: Spermine.4HC1 (10 mM). 
This protocol was then applied to each of the remaining eight wells, with the amount 
of solutions A - C being varied slightly in each well, by 1 or 2 p1, in order to 
establish the best conditions for crystal formation. The wells were then covered with 
glass microscope slides with vacuum grease applied to ensure an efficient seal. The 
plate was maintained at 2770K and examined daily under a microscope to follow the 
process of crystallisation. 
d[CGCLñMeGAATTIGCG] 
The self-complementary dodecamer d[CGC06MeGAA'ITI'GCG] 2 is closely related 
in sequence to the native dodecamer (Wing 1980). Crystals were grown at 2770K 
and pH 6.3 from 25 pl drops containing the oligonucleotide (1.0 mM), magnesium 
chloride (33 mM), 2-methyl-2,4-pentanediol (16.7%), spermine (1.25 mM) and 
sodium cacodylate (5 mM). A single crystal of dimensions 1.3 x 0.3 x 0.3 mm was 
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mounted in a sealed glass capillary and X-ray data collected by Dr. G. Leonard., as 
discussed in appendix i. 
4.2.3. Nuclear Magnetic Resonance. 
1H NIvIR spectra were recorded on the following spectrometers. 
Brucker WH360, Brucker WP200 and Brucker WP80. All chemical shifts were 
quoted in ppm relative to trimethylsilane (8 = 0). 
31p NMR were recorded on a Jeol JMN FX90Q spectrometer. 
4.2.4. Mass Spectrometry. 
Mass spectra were obtained by positive ion Fast Atom Bombardment (FAB) on a 
Kratos MS50 mass spectrometer in a matrix of either thioglycerol or 3-NOBA. 
4.2.5. Elemental analysis. 
C, H and N micro analysis was performed on a Perkin Elmer 240 elemental analyser. 
4.2.6. Ultraviolet spectra. 
All ultraviolet spectroscopy was carried out using a Perkin Elmer Lambda 15 
spectrophotometer controlled by an IBM-PS2 microcomputer equipped with the 
PECSS software package. 
4.2.7. Melting points. 
These were obtained using a Kofler Hotstage and are uncorrected. 
4.2.8. Flash Chromatography. 
This was carried out under slight nitrogen pressure (0.5 bar) using Fluka silica 60, 
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mesh (230-240). In all cases the silica gel was suspended in the eluent and sonicated 
for 15 mm. prior to wet packing. 
Technique A:- For compounds containing the 2-cyanoethyl-N,N'-diisopropyl-
phosphoramidite functionality the silica was oven dried at 120°C, cooled in a 
desiccator suspended in eluent containing 2% triethylainine and sonicated for 15 
mm. After wet packing the column was washed with three column volumes of eluent 
before loading the sample. 
4.2.9. Oligonucleotide synthesis and purification. 
All oligonucleotides were synthesised by the .solid phase method on an Applied 
Biosystems 380B or 381A DNA synthesiser, using standard phosphoramidite 
chemistry (Beaucage 1992 and 1981, Matteucci 1981 and Letsinger 1976). Synthesis 
reagents were purchased from Applied Biosystems except for 5'-(4,4'-dimethoxy-
trityl) -N2-isobutyryl-Oó-methyl-2'-deoxyguanosine-3 '- [2-cyanoethyl -N,N'-diisoprop-
yl]-phosphoramidite, which was purchased from Glen Research, 4I0  
5e1-4 VA. 22r1ô 
Oligonucleotides were cleaved from the solid support with concentrated aqueous 
ammonia, deprotected by heating the solution at 600C for 8 hours and subsequently 
purified by anion-exchange chromatography (DEAE cellulose), followed by reversed 
phase HPLC (method 2). Desalting of the oligonucleotide was carried out on a 
Sephadex G-10 column prior to lyophilisation. For oligonucleotides containing 
06MedG, the following protocol was observed. The 5'-dimethoxytrityl-N2-
isobutyryl-06-methyl deoxyguanosine-3'-cyanoethyl phosphoramidite monomer was 
used to introduce OóMedG and the fully assembled oligonucleotide was cleaved 
from the solid support and deprotected in a 5% solution of 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) in anhydrous methanol for two weeks at 
ambient temperature in an atmosphere of nitrogen (Kuzmich 1983). At no time was 
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the oligonucleotide exposed to ammonia, as this can lead to the slow conversion of 
06MedG to 2,6-diaminopurine (Borowy-Borowski 1987). The DBU was removed 
with Dowex-50 cation exchange resin (Na+ form). Subsequent purification and 
lyophilisation was carried out as above. 
4.2.9a. Determination of phosphoramite coupling efficiency. 
During oligonucleotide synthesis the 4,4',-dimethoxytrityl moiety is cleaved from the 
growing chain using a dichioromethane solution, containing 3% trichloroacetic acid, 
prior to the addition of the next monomer unit. The removal of this protecting group 
generates a 4,4'-dimethoxytrityl cation which has a vivid orange colour. Collection 
of these trityl fractions after each monomer addition and measurement of the visible 
absorbance at 495 nm, (A495), of each fraction gives an indication of the coupling 
efficiency. This was determined as shown below. 
Each fraction was diluted with toluene-4-sulphonic acid (0.1 M) in anhydrous 
acetonitrile to a volume of 100 ml into a standard flask and the absorbance at 495 nm 
determined spectrophotometrically, the coupling efficiency was established 
according to the following equation. 
C.E. =X/Yx 100% 
Where :- 
C.E = Coupling Efficiency. 
X = A495 of trityl fraction n + 1. 
Y = A495 of trityl fraction n. 
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4.2.9b. Determination of oligonucleotide concentration. 
Oligonucleotides were synthesised in multimihigram quantities by combining several 
1 .tM syntheses. The concentration of oligonucleotides however, is best defined in 
terms of optical density per millilitre (OD I ml), an arbitrary unit, which corresponds 
to the UV absorbance of a 1 ml aqueous solution of the oligonucleotide at 264 nm, in 
a 1 cm path length. The optical density is determined by the following equation: 
OD = (Au4 x VC x Vtot.)/Va 
Where: 
V. = Volume of the oligonucleotide aliquot added to the UV cell. 
Vc = Volume of water contained in the UV cell. 
Vt = Total volume of oligonucleotide sample. 
4.2.9c. Reversed Phase HPLC. 
The bases i'wai,I .1o, 	oligonucleotide chains all have characteristic UV spectra 
with maxima in the region 250 to 300 nm, (Figures 4.1a to 4. le). Hence, the HPLC 
elution profile of an oligonucleotide is monitored between these limits, usually at 
264 nm for a dilute sample (analytical injection) and 294 nm for a more concentrated 
preparative injection. As can be seen from the UV spectrum of a typical 
oligonucleotide, Figure 4. if [dCGC06MeGAATTTGCG], there is a broad 
maximum Ca. 257 nm which drops off to zero by 305 nm. Therefore careful 
monitoring around 260 nm allows the detection of very small amounts of 
oligonucleotide impurities and by "de-tuning" and adjusting the wavelength to 294 
nm purification of larger samples can be acheived without overloading the detector. 
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Figure 4.1. 
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Method 1. Method employed for the analysis of enzyme digests of oligonucleotides 
containing 06MedG. 
Detection: UV absorbance at 264 nm. 
Buffer A: Potassium acetate (10 mM adjusted to pH 5.0 with TFA). 
Buffer B: Acetonitrile : Water (3: 1, v/v). 
NMI TIM M1 1 
Flow rate = 2 ml / mm. 
Time(min) 0 6 11 15 16 26 
Buffer A(%) 95 95 70 70 95 95 
Buffer B(%) 1 5 5 30 30 5 5 
Method 2. Method employed for the purification of oligonucleotides and enzyme 
digest analysis. 
Detection: UV absorbance. Analytical at 264 nm, Preparative at 294 nm. 
Buffer A: Ammonium acetate (100 mM, pH 7.3). 
Buffer B: 20% Acetonitrile in aqueous ammonium acetate (100 mM, pH 7.3). 
Conditions 
Flow rate = 3 ml / mm. 
Time(min') 0 3 4 24 25 28 29 30 
BufferA(%) 100 100 90 30 0 0 100 10 
BufferB(%) 0 0 10 70 100 100 0 0 
Method 3. This method was used to establish the identity of 80xodG by coelution 
with a standard sample. The work was carried out by Dr. E. Booth at the Shell 
Research Centre, Sittingbourne, using Knaver 64 (2) pumps connected to an 
Ultrasphere ODS (10 mm x 250 mm) column controlled by a Kontron series 2000 
programmer. Sample detection was obtained using a Rapiscan SA 6508 UV detector 
with elution being carried out isocratically using (8%) methanol / water at a flow rate 
of 2.5 mi/min. 
HPLC purification of oligonucleotides. 
All HPLC analyses were carried out on a Perkin Elmer series 410 LC HPLC system 
or with a Gilson system 306 equipped with a 115 UV detector and an 811 B dynamic 
mixer controlled by a DCS computer with Gilson 712 software. Each system was 
equipped with an Aquapore, Octyl (C8) column, and an octadecyl (C18) Pellicular 
guard column. 
Analytical HPLC ws carried Out using method 2 above by injecting a solution of the 
oligonucleotide (0.1 OD) in ammonium acetate (100 mM, 0.7 ml), and monitoring at 
264 nm and 0.1 absorbance limits  full Scale (AUFS). 
Preparative HPLC was carried out using method 2 and by injecting the product of a 
1 IIM DNA synthesis (50 OD approx.) dissolved in ammonium acetate (100 mM, 0.7 
ml) and monitoring at 295 nm and 1 AUFS. 
4.2.10. Enzymatic digestion of oligonucleotides. 
Oligonucleotide digestion by enzymatic methods allows the identification of the 
nucleoside composition. The two enzymes used in this procedure are snake venom 
phosphodiesterase-1, which cleaves the oligonucleotide into its constituent 
nucleoside-5'-phosphates, and alkaline phosphatase, which catalysis the hydrolysis of 
the nucleoside-5'-phosphates into nucleosides. 
Solution A: - Phosphodiesterase-1 (0.5 mg, 0.5 units) was placed in an eppendorf 
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tube and dissolved in water (50 j.tl). 
Phosphodiesterase-1 (Type vii: Crotalus Atrox venom, 0.1 unit/mg of solid). 1 unit 
will hydrolyse 1.0 mM of bis(p-nitrophenyl)phosphate per minute (pH 8.8, 370C) 
Solution B:- Alkaline Phosphatase (1 l.t1, 0.15 units) was placed in an eppendorf tube 
and dissolved in water (19 p.!). 
Alkaline Phosphatase (Type iii-NE-Coli, 31 units/mg of protein). 1 unit will 
hydrolyse 1 mM of-niirophenylphosphate (pH 10.4, 370C). 
The oligonucleotide (1 OD) was dissolved in buffer [NaCl (1M), Tris (50 mM, pH 
8.8 with HC1 (1M)]. Phosphodiesterase (solution A, 5 p1) and alkaline phosphatase 
(solution B, 1 p.!) were added and the solution maintained at 370C overnight before 
being examined by RP-HPLC, method 1, (injecting 0.1 OD of the sample). 
4.2.11. Ultraviolet melting studies. 
All data were recorded on a Lambda 15 ultraviolet-visible spectrophotometer 
controlled by an IBM-PS2 microcomputer. Ultraviolet melting data were collected 
and processed using the PECSS software package. The temperature of the sample 
cell was controlled by a Peltier block with a heating rate of one degree centigrade per 
minute. The absorbance (264 nm) of the sample was measured at intervals of ten 
seconds and the data were converted from absorbance versus time to absorbance 
versus temperature by the PECSS software. The melting temperature (T m) was 
defined as the temperature which corresponds to the maximum point of the first 
derivative of the melting curve. All curves were in triplicate. 
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Theory of Ultraviolet melting (relating T. to Q. 
The ultraviolet melting technique depends upon the assumption that two 
complementary single strands of DNA are in equilibrium with the double stranded 
form and that the double stranded form has a lower UV absorbance than single 
strands. This difference in absorbance between the two forms is known as the 
hyperchromicity of DNA. Therefore if the initial DNA single strand concentration 
(CJ is known, then by relating this with the melting temperature, (T m), 
thermodynamic parameters can be derived as shown below in Equation 1. Cmark, j 197) 
Equation-1. 
For self-complementary oligonucleotides 
A + A— 	 B 
Total concentration of A is C 1 
Total concentration of B is Cj2. 
If a is the fraction of strands forming a duplex at any given time then we 
can write the concentrations of A and B at any given time as: 
[A] = (1-(x)C 1 and [B]=aCJ2 
K = [B]b/[A]a 
Kseff.comp . = 
AtTm aO.4l4,K0.602/Ct 
Kself.comp. = 1.204/C 1 
-RT1nK = AH4 - TAS4' 
In 1.204/Q = AH/RTm + AS4'/R 
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In C1 = AH/RTm - AS4'/(R + in 1.204) 
lfTm = R.InC1/ AH + [ASs - In (1.204).R]/ LH5 
From equation 1 it is clear that Tm a InCa and therefore a plot of 1/T m against 1nC 
will yield a straight line of gradient R/zH5 which bisects the Y-axis at [ASS - 
ln(1 .204).R]/AHS. 
4.2.11a. Measurement of T. as a function of C. 
Using 5 mm path length UV cells, the spectrophotometer was background corrected 
with buffer in both cells [NaCl (1 Al), NaH 2PO4 (10 mM), EDTA (1 mM), pH 7, 
with NaOH (1 M)]. To the sample cell, containing buffer (1.4 ml), was added the 
oligonucleotide (2.8 OD) and the data was collected as described above. Successive 
oligonucleotide dilutions were then made, and the T. was determined at six different 
oligonucleotide concentrations over a 20 fold range. The last two dilutions were 
made by transferring the oligonucleotide solution into a 1 cm path length cell. 
4.2.11b. Measurement of T m as a function of pH. 
The sample cell was firstly filled with buffer [NaH 2PO4 (0.1 Al), adjusted to the 
appropriate pH by addition of NaOH (1 Al)] and a baseline correction applied against 
a reference cell containing the same buffer. The oligonucleotide (1.2 OD) was then 
added to the sample cell and the data was collected as described above. 
Ma. Oligonucleotide d[CGCQfiMeGAATTSGCG]. 
1.1b. Oligonucleotide d[CGCQfiMeGAA1T[GCG]. 
8-Bromo-2'-deoxyguanosine.- To a rapidly stirred suspension of 2'-
deoxyguanosine (5g, 14.4 mM) in water (30 ml) was added, dropwise, saturated 
bromine water, (c.a. 150 ml), until the yellow colouration persisted. The mixture was 
then cooled in an ice / water bath and examined by (t.1.c. system H. Rf sm = 0.4, 
Rfprod. = 0.6). Saturated bromine water was then added in aliquots until no 2'- 
deoxyguanosine remained. The cold suspension was then filtered, washed with cold 
water followed by cold acetone and recrystallised from water / methanol (30:1, 1.5 
L), maintaining the temperature below 80°C, to give 8-bromo-2'-deoxyguanosine 
(3.77g. 58%) as white needles. m.pt . 207°C dec. (Holmes 1964, 210°C dec.). [Found 
34.4%C, 3.4%H and 20.2%N, Caic. 34.7%C, 3.5%H and 20.2%N]. 8H (360 MHz; 
d6DMSO)2.1 (qd, 1H, 2'H), 3.1 (quin. 1H, 2'H), 3.4 (quin. 1H, 5'H), 3.55 (quin. 1H, 
5'H), 3.8 (sext. 1H, 4'H), 4.2 (m, 1H, 3'H), 4.8 (t, D 20 exch. 1H, 5'OH), 5.2 (d, D20 
exch. 1H, 3'OH), 6.1 (t, 1H, 1'H), 6.3 (s, D20 exch. 2H, N2H), 10.8 (s, D20 exch. 
1H, N(1)H). m/z 345 and 347 (M+H)+. Xmax (pH 5.6) 260 nm, 278(sh). 
8-Methoxy-2'-deoxyguanosine.- To a stirred solution of sodium methoxide, 0.8 g 
Na in methanol 15 ml, was added anhydrous DMSO (20 ml) followed by a solution 
of 8-bromo-2'-deoxyguanosine (2g, 5.8 mM) in anhydrous DMSO (40 ml). The 
reaction mixture was protected from moisture and heated at 60°C for 8h. then cooled 
to room temperature and neutralised with Dowex (NH- form). After filtering the 
Dowex the clear filtrate was concentrated under reduced pressure and precipitated 
into rapidly stirred diethyl ether (1 L) to yield the product as a pale yellow solid. (H. 
RI = 0.55). 8H (200 MHz; d6DMSO) 2.1 (br. m, 1H, 2'H), 2.85 (br. m, 1H, 2'H), 
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3.25 to 3.6 (br. m, 2H, 5'H), 3.8 (m, 1H, 4TH) 3.95 (s, 3H, C8-OMe), 4.35 (m, 1H, 
3H) 4.75 (br. s, 1H, D20 exch. 5'OH), 5.25 (br. s, 1H, D20 exch. 3'OH), 6.1 (t, 1H, 
1'H), 6.75 (s, D20 exch. 2H, N2H), 10.7 (br. s, D 20 exch. 1H, N(1)H). [Found: m/z 
= 298.11512 (M+H)+ Caic. for C 11 H16N505 = 298.115131 m/z*  298 (M+H)+ and 181 
(M+HdR) 4 . Xmax(pH 5.6) 282nm, 247nm,. (pH 14) 260nm, 270nm(sh). 
*Obtained by laser desorption time of flight mass spectrometry. 
4. 	5 '-O-(4,4 '-Dimethoxytrityl)-N2 -((dimethylamino)methylene]-8-methoxy-2 '- 
deoxyguanosine. - 8-Methoxy-2'-deoxyguanosine (1.1g, 3.7mM), dried by 
evaporation of anhydrous pyridine (3 x 10 ml), was suspended in anhydrous pyridine 
(15 ml), protected from moisture and dimethylformamide diethyl acetal (2.2 ml, 4 
eq) was added. The mixture was stirred overnight at 400C, concentrated in vacuo and 
the oily residue was dried by evaporation of anhydrous pyridine (3 x 10 ml) before 
being dissolved in anhydrous pyridine (15 ml) and protected from moisture with a 
guard column. To this solution was then added, with stirring, triethylamine (1.1 ml, 
2 eq), 4-dimethylaminopyridine (22 mg, 0.05 eq) and 4,4'-dimethoxytrityl chloride 
(1.9 g, 1.5 eq). After two hours, water (15 ml) was added and the product extracted 
into ethyl acetate (3 x 75 ml), dried (MgSO 4) and concentrated in vacuo. The residue 
was purified by silica gel chromatography (0 - 8% methanol I DCM / 2% TEA) and 
the product concentrated to a foam in vacuo (1.46 g, 66% ). (F. Rf = 0.4 and 0.3). 
oH (200 MHz; CDC13), 2.15 (m, 1H, 2'H), 3.05 and 3.1 (2s, 6H, N 2NMe2) , 3 (m, 
1H, 2'H), 3.25 (m, 1H, 5'H), 3.65 (m, 1H, 5'H), 3.65 (s, 6H, DMTr-OMe), 3.8 (s, 
3H, C8-OMe), 4 (br. d, 1H, 4'H), 4.27 (br, 1H 3'H), 5.24 (br, 1H, D 20 exch. 3'OH), 
6.2 (t, 1H, l'H), 6.75 (br, 4H, 3,5,3',5' DMTr-H), 7.25 (br, 9H, DMTr-H), 8.4 (s, 1H, 
N2CHN), 11.33 (bs, 1H, D 20 exch. N(1)H). [Found mlz = 655.28799 (M+H)+ Caic. 
for C35H39N607 = 655.288001. m/z 303 (DMTr)+ and 237 (M+H-dR)+. 
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5. 	5'(0)-(4,4 '-Dimethox trityl)-N2-[(dimethylanino)methylene]..g..metJ,xy..2 '• 
deoxyguanosine-3 ' - (0)-[(2-cyanoethyl) -(N,N -diisopropyl)]-phosphora,njdjte.To 	a 
sealed flask, flushed with argon and containing 5'(0)-(4,4'-dimethoxytrityl)-N2-
[(dimethylamino)methylene] -8-methoxy-2'-deoxyguanosine (400 mg, 610 tM) dried 
by evaporation of anhydrous DCM (3 x 10 ml), was added anhydrous DCM (20 ml), 
N,N'-diisopropylethylamine (4 eq. 0.43 ml) and 2-cyanoethyl-N,N'-
diisopropylphosphoramidochloridite (1.5 eq. 0.21 ml). After stirring for thirty 
minutes, ethyl acetate [20 ml, dried by storing over MgSO 4 for 24 h. and filtering] 
was added and the organic phase washed with KC1 (300 mM, 2 x 30 ml) followed by 
5% sodium carbonate solution (2 x 30 ml). The organic phase was then dried 
(MgSO4), concentrated in vacuo and the residue purified by silica gel 
chromatography, technique A (see experimental 4.2.8.), (20% ethyl acetate / DCM) 
and concentrated in vacuo to a yellow gum (455 mg, 87%). (0. Rf = 0.25). [31P nmr. 
s, 148.75 lppm]. 8H  (200 MHz; CDC13), 1.2 (br. m, 12H, 3'NIpMe 2), 2.3 (br. m, 1H, 
2'H), 2.45 (t, 1H, 3'P-0-CHa), 2.6 (t, 1H, P-0-CHb), 3.1 (s, 6H, N2NMe2), 3.25 (t, 
2H, 3'NC-CH2), 3.65 (br. m, 4H, 5'H and 3'0-NCH) 3.8 (s, 6H, DMTr-OMe) 3.95 
(d, 3H, C8-OMe) 4.15 (m, 1H, 4'H), 4.75 (br. m, 1H, 3'H) 6.3 (t, 1H, Ili), 6.75 (m, 
4H, trityl 2,6,2',6'H), 7.1 to 7.7 (br. m, 9H, trityl H), 8.45 (d, 1H, N2methyleneH), 
8.9 (br. s, 1H, D20 exch. N(1)H). [Found m/z = 855.39581 (M+H)+ Caic for 
C44H56N80831P = 855.39584]. m/z = 637 (M-i-H-C9H1802N2P)+ and 303 (DMTr)+. 
6.1. Oligonucleoride. d[CCCCC8MeOGTCCCCC]. 
6.2 Oligonucleotide. CPG ----- d[C*C*C*C*C*8MeOG*TC*C*C*C*C*]. 
Synthesis was carried out as described in the experimental section but no 
deprotection was employed. CPG indicates that 6.2. remained attached to the resin 
beads and C* and 8MeOG* represent protected bases on the oligonucleotide chain. 
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7. 8-Benzyloxy-2'-deoxyguanosine:- To a stirred solution of sodium benzyloxide, 
prepared by addition of sodium (0.6 g, 26 mM) to purified benzyl alcohol (25 ml) 
and sonicating for 25 mm., was added dry DMSO (15 ml) followed by 8-bromo-2'-
deoxyguanosine (1.3 g, 4.3 mM) dissolved in dry DMSO (25 ml). The reaction 
mixture was protected from moisture and maintained at 60°C for 48 hr., with 
stirring, before cooling to room temperature and neutralising by the addition of 
Dowex (NH4+). After filtering the Dowex, the neutral eluent was concentrated, as 
far as possible, on a rotary evaporator, under oil pump vacuum, before precipitation 
into rapidly stirred diethyl ether (600 ml). The pale yellow precipitate was then 
filtered and dried in vacuo to yield the crude product (1.3 g, 81%). (H. Rf = 0.68). 
H (360 MHz; d6-DMSO) 2 (qd, 111, 2'H), 2.85 (quin. 1H, 2'H), 3.4 (m, 2H, 5'H), 
3.75 (d, 1H, 4'H), 4.25 (br, 1H, 3'H), 4.8 (t, D20 exch. 1H, 5'OH), 5.2 (d, D20 exch. 
1H, 3'OH), 5.45 (s, 2H, C8-OCH2), 6.1 (t, 1H, 1'H), 6.3 (s, D 20 exch. 2H, N2H), 
7.4 (br, 5H, C8-Ph), 10.6 (s, D20 exch. 1H, N(1)H). [Found m/z = 374.14643 
(M+H)+ Calc for C 17H19N505 = 374.14644]. UV (pH 5.6) kmax = 248, 290. 
9. 5 ',3 '-0 -N2-Triisobutyryl-8-oxo-7-hydro-2 '-deoxyguanosine:- 8-Benzyloxy-2'-
deoxyguanosine (1 g, 2.7 mM) was dried by evaporation of anhydrous pyridine (3 x 
10 ml) then suspended in anhydrous pyridine (20 ml) and cooled in an ice / water 
bath. Isobutyryl chloride (2.8 ml, 27mM) was then added, with stirring, and the 
mixture protected from moisture with a guard column. After 2 hr. the reaction was 
poured into a solution of 5% sodium hydrogen carbonate (50 ml) and the product 
extracted with ethyl acetate (3 x 50 ml), dried (MgSO4) and concentrated in vacuo to 
an oil. The residue was then purified by silica gel chromatography (0 - 5% methanol 
/ DCM) and concentrated in vacuo to a foam (0.94 g, 60%), compound 8. The 
triisobutyiyl-8-benzyloxy-2'-deoxyguanosine (0.7 g, 1.2 mM) was then dissolved in 
ethyl acetate I ethanol (6:1, 30 ml) and added to a beaker containing 10% Pd / C (80 
mg) and nitrogen was blown over the vessel. The reaction mixture was then placed 
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i-nto a hydrogenator under 50 psi. of hydrogen and shaken at room temperature for 
36 hr. The mixture was then filtered twice through celite and the filtrate concentrated 
in vacuo prior to purification on silica gel chromatography (0- 5% methanol I DCM) 
to yield the product (0.25 g, 42%). (K. Rf = 0.34). 8H (200 MHz; CDC13), 1 (d, 611, 
N2IbMe), 2.2 (m, 1H, 2'H), 2.5 (m, 2H, 3',5'IbCH), 2.8 (sept. 1H, N2IbCH),  3 (m, 
111, 21-1), 4.1 (m, 211, 5'Il), 4.3 (m, 1H, 4'H), 5.4 (m, 111, 3'H), 6 (t, 1H, 1'H), 11.2 
(s, D20 exch. 1H, N(7)H), 11.5 (s, D 20 exch. 1H, N211), 12 (s, D 20 exch. 1H, 
N(l)H). [Found m/z = 494.22508 (M+H)+ Caic for C 221132N508 = 494.225071. m/z 
= 238 (M+H-dR)+, 168 = (M+H-dR-N21b)+. 
10. 5 ',3 '-Bis-O-acetyl-8-bromo-2 '-deoxyguanosine.- Bromine solution [bromine, 4 
ml, in ethanol / water (1:1 v/v. 100 ml)] was slowly added to a stirred suspension of 
3',5'-bis-0-acetyl-2'-deoxyguanosine (5g, 14.2mM) in ethanol / water (1:1 v/v. 25 
ml) until the yellow colour persisted. At this point the reaction was cooled in an ice / 
water bath, examined on tic (F. Rfsm 0.18, Rfpod 0.3) and bromine solution added 
until no starting material remained. The solid was then filtered, washed with diethyl 
ether and recrystallised from ethanol / water (9:1 v/v, 300 ml) to give 5',3'-bis-0-
acetyl-8-bromo-2'-deoxyguanosine (4.05 g, 66%) as small white crystals. m.pt .-
darkens at 2180C and does not then melt below 350°C. [Found 39.3%C, 4.0%H, 
15.8%N, Caic. 39.1%C, 3.7%H, 16.2%N]. oH (200 MHz; d6DMSO).  2 and 2.1 (s, 
611, 5',3'AcMe), 2.4 (m, 1H, 2'H), 3.5 (bm, 111, 2'H), 4.2 (m, 211, 5'H), 4.35 (m, 1H, 
4'H), 5.4 (m, 1H, 3'H), 6.2 (t, 111, 1'H), 6.55 (s, D20 exch. 211, N2H), 10.9 (s, D 20 
exch. 111, N(1)H). m/z 430 and 432 (M+H)+, 447 and 449 (M+H20)+. 
11.1. 5 ',3 '-Bis-O-acezyl-N 2-isobuzyryl-8-bromo-2 '-deoxyguanosine .- 5',3'-Bis-0-
acetyl-8-bromo-2'-deoxyguanosine (5 g, 11.6 mM), dried by evaporation of 
anhydrous pyridine (3 x 10 ml), was suspended in anhydrous pyridine (80 ml). The 
stirred suspension was protected from moisture, cooled in an ice I water bath and 
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isobutyryl chloride (5eq. 6 ml) added. After 15 minutes the reaction was quenched 
by pouring it slowly into 5% sodium hydrogen carbonate solution (200 ml) and the 
product was extracted into ethyl acetate (3 x 75 ml), dried (MgSO4) and concentrated 
in-"acuo. The residue was purified by silica gel chromatography (0 - 5% methanol I 
DCM) and concentrated to a foam in vacuo (5 g, 86%). (E. Rf = 0.6) 5H (200 MHz; 
CDC13) 1.25 (over.d, 611, N2IbMe), 2.1(2s, 6H, 5',3'AcMe), 2.4 (br. m, 1H, 2'H), 
2.75 (sept. 1H, N2IbCH),  3.25 (br. m, 1H, 2'H), 4.3(m, 211, 5'H), 4.8 (d, 1H, 4'H), 
5.45 (br. d, 1H, 3'H), 6.3 (t, 111, VH), 8.6 (br. s, D 20 exch. 111, N2H). [Found: m/z = 
500.078 13 (M+H)+ Calc. for C 18H23N50779Br = 500.078 12 and m/z = 502.07618 
(M+H)+ Caic. for C 18H23N50781Br = 502.076 15].  m/z = 300 and 302 (M+H-dR)+. 
11.2 	5 ,3 '-Bis-O-acezyl-N2-phenylacetyl-8-bromo-2 '-deoxyguanosine.- 	To 	a 
suspension of 5',3'-bis-0-acetyl-8-bromo-2'-deoxyguanosine (4 g, 9.3 mM), dried by 
evaporation of anhydrous pyridine (3 x 10 ml), in anhydrous pyridine (50 ml) was 
added phenylacetic anhydride (9.4 g, 4 eq.) and the mixture refluxed for 1.5 h. It was 
then allowed to cool to room temperature before adding saturated sodium hydrogen 
carbonate (50 ml) and extracting the product with dichioromethane (3 x 50 ml). The 
organic phase was then dried (MgSO4), concentrated in vacuo, purified by silica gel 
chromatography (0 - 3% methanol I DCM) and the pure product concentrated to a 
foam (3.77 g, 73%). (F. Rf = 0.62). oH (360 MHz; CDC1 3), 2.1 (2s, 611, 5',3'AcMe), 
2.5 (m, 1H, 2'H), 3.25 (quin, 1H, 2'H), 3.8 (s, 211, N2PhCH2), 4.4 (m, 211, 5'H), 4.9 
(m, 111, 4'H), 5.5 (d, 111, 3'H), 6.4 (t, 111, 1'H), 7.4 (m, 511, N2Ph-H), 9.4 (s, D 20 
exch. 1H, N2H), 12.0 (s, D20 exch. 111, N(1)H). [Found: m/z = 548.07814 (M+H)+ 
Calc. for C22H23N50779Br = 548.078 12 and m/z = 550.07614 (M+H)+ Caic. for 
C22H23N5078 1 Br = 550.076151. m/z = 348 and 350 (M+H-dR)+ and 270 (M+H-dR-
Br)+. 
12. 5 '-0-(4,4 	 '-deoxyguanosine.- To an ice 
cold solution of 	 (1.2 g, 
2.4 mM) in pyridine I methanol / water (55:25:20, 25 ml) was added pyridine / 
methanol / 2 M NaOH (55:25:20, 25 ml). After five minutes the mixture was 
neutralised by the addition of Dowex (pyridinium form) which was then filtered and 
washed with pyridine / methanol (1:1). The neutral filtrate was then concentrated in 
vacuo and the paste dissolved in methanol (1 ml). The product was precipitated by 
addition of diethyl ether (10 ml), filtered and further washed with diethyl ether to 
give N2-isobutyryl-8-bromo-2'-deoxyguanosine as a white powder (0.81 g, 81%) 
which was dried by evaporation of anhydrous pyridine (3 x 10 ml). The solid was 
then suspended in anhydrous pyridine (25 ml) and triethylamine (0.55 ml, 2 eq.), 4-
dimethylaminopyridine (12 mg, 0.05 eq.) and 4,4'-dimethoxytrityl chloride (0.81 g, 
1.2 eq.) were added with stirring and the exclusion of moisture. After 2h. water (20 
ml) was added and product extracted with ethyl acetate (3 x 35 ml), dried (MgSO4) 
and concentrated in-vacuo. The resultant oil was then purified by silica gel 
chromatography (0 - 5% methanol / DCM /2% TEA) and concentrated invacuo to a 
foam (1.1 g, 79%). (F. Rf = 0.5). 8H  (360 MHz; d6DMSO) 1.1 (2d, 6H, N2IbMe), 
2.3 (m, 1H, 2'H), 2.75 (sept. 1H,.N2IbCH), 3.1 (dd, 1H, 5'H), 3.2 (m, 1H, 2'II), 3.4 
(t, 1H, 5'H) 3.7 (2s, 6H, DMTr-OMe), 4.0 (m, 1H, 4'H), 4.5 (m, 1H, 3'I-l), 5.2 (d, 
D20 exch. 1H, 3'OH), 6.3 (t, 1H, VH), 6.75 (2d, 4H, 3,5,3,5' DMTr-H), 7.1 - 7.4 
(m, 9H, DMTr-H), 11.3 (br. s, D 20 exch. 1H, N2H), 12.0 (br. s, D20 exch. 1H, 
N(1)H). m/z = 821 and 819 (M+H+TEA)+, 303 (DMTr)+: m/z 716.6 and 718.6 (M-
H)-. 
13. 5 '-0-14,4 '-Dimethoxyrrizyl]-8-bromo-2 '-deoxyguanosine:- To a solution of 5'-0-
[441-dimethoxytrtyl]-N2 isoburyl.8..bromo2'..dxyguanosjne (200 mg, 0.28 
mM) in THF (5 ml) was added NaOH (0.24 g, 10 eq). This resulted in the formation 
of two layers and the mixture was rapidly stirred at 55°C. After 24 hr. the reaction 
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was complete (G. Rf  = 0.28) and the mixture was then neutralised with Dowex 
(pyridinium form), before purifying by flash chromatography (0 - 10% methanol / 
DCM / 2%TEA). Concentrating in vacuo gave a foam (103 mg, 57%). oH (360 
MHz; d6DMSO)  2.3 (m, 111, 2'H), 3.1 (m, 2H, 2',5'H), 3.4 (t, 1H, 5TH) 3.7 (s, 611, 
DMTr-OMe), 3.9 (bq, 1H, 4'H), 4.5 (br, 1H, 3'Il), 5.2 (d, D20 exch. 1H, 3'OH), 6.2 
(t, 111, 1B), 6.4 (s, D20 exch. 2H, N2H),  6.8 (2d, 4H, 3,5,3',5'DMTr-H), 7.1-7.4 (br, 
9H, DMTr-H), 10.8 (br. s, D20 exch. 1H, N(1)H. m/z = 751 and 749 (Br present) 
[M+H+TEA]+, m/z 303 (DMTr)+. m/z = 648 [M-H]-. 
14. N2-(4,4 '-Dimethoxytrityl)-8-bromo-2 '-deoxyguanosine.- 5',3'-Bis-0-acetyl-8-
bromo-2'-deoxyguanosine (0.55 g, 1.3 mM) was dried by evaporation of anhydrous 
pyridine (3 x 10 ml) and dissolved in anhydrous pyridine (10 ml). The solution was 
protected from moisture and triethylamine (0.36 ml, 2 eq.), 4-dimethylaminopyridine 
(8 mg, 0.05 eq.) and 4,4'-dimethoxytrityl chloride (0.83 g, 1.2 eq) were added with 
stirring. After 2 h. water (10 ml) was added and the product was extracted into ethyl 
acetate (3 x 20 ml), dried (MgSO 4) and concentrated to a foam in vacuo. The foam 
was then dissolved in a solution of pyridine / methanol / water (55:25:20, 25 ml), 
cooled in an ice bath and pyridine / methanol /2 M NaOH (55:25:20, 25 ml) added. 
After ten minutes the mixture was neutralised by the addition of Dowex, (pyridinium 
form), which was then filtered and washed with pyridine / methanol (1:1). The 
neutral eluent was concentrated invacuo, the residue washed with diethyl ether, 
purified by silica gel chromatography (0 -15% methanol / DCM / 2% TEA) and 
concentrated in vacuo to a foam (0.68 g, 82%). 0H  (200 MHz; d6DMSO)  1.3 (bm, 
111, 211), 2.3 (br. m, 1H, 2'H), 3 (br. d, 1H, 5'H), 3.5 (m, 2H, 3',5'H), 3.55 (br. s, 1H, 
D20 exch. N2H),  3.75 (s, 6H, DMTr-OMe), 4. (br. s, 1H, D 20 exch. 5'OH), 5 (s, 1H, 
D20 exch. 3'OH), 5.75 (t, 111, YH), 6.75 - 7.3 (br, 13H, DMTr-H), 7.6 (s, 1H, D 20 
exch. N(1)H). []Found: m/z = 648.14585 (M+H)+ Caic. for C 31H31 N50681 Br = 
648.145811 m/z= 648 and 650 (M+H)+, 749 and 751 (M+H+TEA) and 303 
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(DMTr)+. 
15.1. 5',3 '-Bis-O-acezyl-N 2-isoburyiyl-8-(-nitrophenylthio)-2 '-deoxyguanosine .- A 
solution of 5',3'-bis-0-acetyl-N2-isobutyryl-8-bromo-2'-deoxyguanosine (0.75 g, 1.5 
mM) and -nitrothiophenol (0.28 g, 1.2 eq.) in anhydrous pyridine (10 ml) was 
maintained at room temperature for 3 h before diluting with water (30 ml) and 
extracting with ethyl acetate (3 x 30 ml). The organic phase was then dried 
(MgSO4), concentrated in vacuo and the residue purified by silica gel 
chromatography (0 - 3% methanol / DCM) and concentrated to a foam in vacuo (0.7 
g, 81%). (G. Rf = 0.64), 5H (200 MHz; CDC1 3) 1.25 (2d, 611, N2IbMe),  2.15 (2s, 
611, 5',3'AcMe), 2.3 (qd, 111, 2'H), 2.75 (sept. 1H, N2IbCH), 3.15 (quin. 1H, 2'H), 
4.3 (m, 211, 5'H), 4.9 (d, 111, 4'H), 5.5 (br. d, 1H, 311), 6.5 (t, iN, 1'H), 7.35 (d, 2H, 
m-NPT-H), 8.1 (d, 2H, Q-NPT-H), 9.3 (s, D 20 exch. 1H, N211), 12.2 (s, D 20exch. 
1H, N(1)H). [Found: m/z = 575.15600 (M+H)+ Caic. for C 24H27N609S = 
575.166011. m/z = 375 (M+H-dR)+. 
15.2. 5',3 '-Bis-O-acetyl-N2 -phenylaceiyl-8-(-nitrophenylthio)-2 '-deoxyguanosine 
A solution of (0.8 g, 
1.5 mM) and -nitrothiophenol (0.28 g, 1.2 eq) in anhydrous pyridine (10 ml) was 
maintained at room temperature for 3 h before diluting with aqueous KC1 (30 ml, 
500 mM) and extracting with ethyl acetate (3 x 30 ml). The organic phase was then 
dried (MgSO4), concentrated inh,acuo  and the residue purified by silica gel 
chromatography (0 - 3% methanol / DCM) and concentrated to a foam in vacua 
(0.94 g, 65%). (0. Rf = 0.65). oH (200 MHz; CDC1 3) 2.1 (s, 611, 5',3'AcMe), 2.25 
(qd, 1H, 2'H), 3.1 (quin. 1H, 2'H), 3.8 (s, 2H, N2PhCH2), 4.3 (m, 211, 5'H), 5 (d, 1H, 
411), 5.45 (m, 1H, 3'H), 6.5 (t, 1H, FH), 7.4 (s, 511, N2Ph-H),  7.4 (d, 2H, -NPT-H) 
8.1 (d, 2H, Q-NPT-H), 9.45 (s, D20 exch. 1H, N2H),  12 (s, D20 exch. iN, N(1)H). 
[Found: m/z = 623.15607 (M-i-H)+ Caic. for C 28H27N609S = 623.15601]. m/z = 423 
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(M+H-dR)+ 
5 '-O-(4,4 '-Dimethoxytrilyl)-N 2 -isobutyryl-8-bromo-2 '-deoxyguanosine-3 ' -0-1(2 -
cyanoethyl) -(N,N' -diisopropyl)]-phosp/zoramjdjre.- After drying the 5'(0)-(4,4'7
dimethoxytrityl)-N2-isobutyiyl-8-bromo-2'-deoxyguanosine (1 g, 1.4 mM) by 
evaporation of dry dichioromethane (3 x 10 ml) an oven dried magnetic stirrer was 
placed in the flask which was then sealed with a septum and flushed with argon. Dry 
dichloromethane (20 ml) was then added and N,N'-diisopropylethylamine (0.5 ml, 2 
eq.) and 2-cyanoethyl-N,N'-diisopropylphosphoramidochlorjcijte(O.5 ml, 2 eq.) were 
added to the white suspension with stirring. After 30 mm. the reaction mixture was 
poured into a separating funnel containing dichloromethane (30 ml) and saturated 
sodium hydrogen carbonate (40 ml) and the reaction washed. The organic layer was 
then dried (MgSO4), concentrated invacuo and the oily residue purified by silica gel 
chromatography, technique A (see experimental 4.2.8.), (20% acetonitrile / DCM) 
and concentrated to a white foam in -vacuo (0.9 g, 71%). [31P  nmr, CDC13: s, 
147.5397ppm.]. (0. Rf = 0.49). m/z = 303 (DMTr)+. UV profile of enzyme digest 









19.1. N2 	 - To a cold solution of 
(0.85 g, 
1.5 mM) in pyridine / methanol / water (55:25:20, 25 ml) was added pyridine / 
methanol / 2 M NaOH (55:25:20, 25 ml). After five minutes the mixture was 
neutralised by the addition of Dowex (pyridinium form) which was then filtered and 
washed with pyridine / methanol (1:1). The neutral filtrate was then concentrated in 
vacuo and the paste dissolved in methanol (1 ml). The product was precipitated by 
addition of diethyl ether (10 ml), filtered and further washed with diethyl ether to 
give the title compound as a pale yellow solid (0.58 g, 80%). 8H (200 MHz; CDC1 3) 
1.15 (d, 6H, N2IbMe), 2.1 (m, 1H, 2'H), 2.8 (quin. 1H, N 2IbCH), 3.1 (m, 111, 2'H), 
3.4 (m, 1H, 5'H), 3.6 (m, 1H, 51-I), 3.75 (d, 1H, 4'H), 4.4 (br. m, 1H, 3'H), 4.75 (t, 
D20 exch. 1H, 5'OH), 5.25 (d, D20 exch. 111, 3'OH), 6.4 (t, 111, iN), 7.5 (d, 2H, in-
NPT-H), 8.25 (d, 211, Q-NPT-H), 11.7 (s, D20 exch. 1H, N2H) 12.25 (s, D 20 exch. 
111, N(1)H). [Found: m/z = 491.13490 (M+H)+ Caic. for C2011 23N607S = 
491.13488]. m/z = 375 (M+H-dR)+. 
19.2. N2 -Phenylacelyl-8-(-njtrophenylrhjo).2 '-deoxyguanosine .- To a cold solution 
of 5 ',3 '-bis-0-acetyl-N2-phenylacetyl-8-(p-nitrophenylthio)-2'-deoxyguanosine (100 
mg, 0.16 mM) in pyridine / methanol / water (55:25:20, 5 ml) was added pyridine / 
methanol / 2 M NaOH (55:25:20, 5 ml). After five minutes the mixture was 
neutralised by the addition of Dowex (pyridinium form) which was then filtered and 
washed with pyridine / methanol (1:1). The neutral filtrate was then concentrated in 
vacuo to give a solid which was washed with diethyl ether (5 ml) and filtered to give 
the product as a pale yellow powder (52 mg, 60%). (F. Rf = 0.6), oH (200 MHz; 
d6DMSO) 2.1 (qd, 1H, 2'H), 3.15 (quin. 1H, 2'H), 3.5 (m, 2H, 5'H), 3.7 (m, 1H, 
4TH), 3.8 (s, 2H, N2CH2), 4.4 (br. m, 1H, 3'H), 6.5 (t, 1H, 1'H), 7.3 (m, 5H, N2Ph-
H), 7.4 (d, 2H, in-NPT-H) 8.1 (d, 2H, Q-NPT-H), 11.9 (s, D 20 exch. 1H, N211), 12.1 
(s, D20 exch. 1H, N(1)H). [Found: m/z = 539.13492 (M+H)+ Calc. for C2 4H23N607S 
111 
= 539.134881. m/z = 422 (M+H-phenylacetyl)+. 
5'-O-(4,4 	 '- 
deoxyguanosine .- To a solution of N2-isobutyryl-8-(-nitrophenylthio)-2'-
deoxyguanosine (0.58 g, 1.2 mM), dried by evaporation of anhydrous pyridine (3 x 
10 ml), in anhydrous pyridine (20 ml) and protected from moisture was added, with 
stirring, triethylamine (2 eq. 0.42 ml), 4-dimethylaminopyridine (0.05 eq. 9 mg) and 
4,4'-dimethoxytrityl chloride (1.2 eq. 0.61 g). After 2 h water (20 ml) was added and 
the product extracted with ethyl acetate (3 x 25 ml), dried (MgSO 4) and concentrated 
in vacuo. The residue was purified by silica gel chromatography (0 - 4% methanol / 
DCM /2% TEA) and concentrated to a foam in vacuo (0.89 g, 95%). (F. Rf = 0.5). 
611 (200 MHz; CDC1 3) 0.9 (d, 6H, N2IbMe), 2 (m, 1H, N2IbCH), 2.2 (m, 1H, 2'Il), 
3.1-3.25 (m, 2H, 2',5'H), 3,4 (m, 1H, 5'H), 3.75 (s, 6H, DMTr-OMe), 4 (br. d, 1H, 
4'H), 4.75 (br. s, D20 exch. 1H, 3'OH), 4.9 (br, 1H, 3'H), 6.4 (t, 1H, 1'H), 6.75 (dd, 
4H, 3,5,3',5' DMTr-H), 7-7.5 (br, 1 1H, DMTr and m-NPT-H), 8 (d, 2H, Q-NPT-H). 
[Found: m/z = 792.25774 (M)+ Caic. for C41 H40N609S = 792.257731 m/z = 894 
(M+H+TEA)+ and 303(DMTr)+. 
5'-0-(4,4 '-Dimethoxytrityl)-N 2-isobutyryl-8-(-nitropheny1thio)-2 '-
deoxyguanosine-3 '-0-1(2 -cyanoerhyl)-(N,N'-diisopropyl)]-phosphoramjdjte.- After 
drying 
deoxyguanosine (0.86 g, 1.1 mM) by evaporation of dry clichioromethane (3 x 10 
ml) an oven dried magnetic stirrer was placed in the flask which was then sealed 
with a septum and flushed with argon. Dry dichioromethane (20 ml) was then added 
followed by N,N'-diisopropylethylamine (0.4 ml, 2 eq.) and 2-cyanoethyl-N,N'-
diisopropylphosphoramidochloridite(O.29 ml, 1.2 eq.) with stirring. After 30 mm. 
the reaction was poured into a separating funnel containing dichloromehthane (30 
ml) and saturated sodium hydrogen carbonate solution (40 ml) and the reaction 
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mixture washed. The organic layer was then dried (MgSO4), concentrated 
in-vacuo 
and the oily residue purified by silica gel Chromatography, technique A (see 
experimental 4.2.8.), (20% acetonitrile / DCM) and concentrated to a yellow foam 
in 
vacuo (0.82 g, 76%). (0. RI = 0.54). [3 1 Pnmr. CDC13, d, 148.7577, 148.1670.] 
[Found: m/z = 993.37341 (M+H)+ Caic. for C50H58N8010pS = 993.37339] m/z = 992 
(M)+, 791 (M+H-C9H18N20p)+ and 303 (DMTr)+. Rf = 0.54 (20% MeCN / DCM). 
UV profile of enzyme digest was consistent with that of the synthesised - 
nitropheny1thio.2'..deoxygu05 kmax  = 277nm. 
22a. Oligonucleotjde. d[CGC8NPTiAAT1'1iGCG] 
22a. Oligonucleotide. d{CGCSNVFjAAT1'G} 
Oligonucleoride. d[CGC8NFAiAATIGCG] 
Oligonucleoticle. d[CGCAAATTSNPTGGCG] 
23. 8-oxo -7-hydro-2'-deoxyg,wsjne.... To a solution of 8MeodG (0.75g, 2.5mM) in 
pyridine (2) / methanol (1) / water (1) (30ml) was. added thiophenol (4m1, lOeq.) 
followed by triethylamine (7m1, 20eq.) and the mixture stirred at 60 0C for 24hr. 
Water (40m1) was then added and after cooling to room temperature the reaction 
mixture was washed with DCM (4 x 50m1). The aqueous layer was then evaporated 
to dryness yielding a yellow gum (0.93g). (A, Rfpr = 0.34, Rj S  = 0.43). bH (200 
MHz; d6DMSO). 1.1 (t, TEA CH3), 1.94 (bm, 1H, 2'H), 2.5 (q, TEA CH2) 2.90 (bm, 
1H, 2'H), 3.5 (bm, 2H, 5'H), 3.75 (br. 1H, 4'H), 4.35 (br. 1H, 3'H), 4.85 (bs. D20 ex. 
1H, 5OH), 5.20 (bs. D20 ex. 1H,3'OH), 6.05 (t, 1H, 1'H), 6.7 (s. D20 ex. 2H, 
N2H), 7.5 and 7.75 (br, pyridine and thiophenol), 10.6 (bs. D20 ex. 1H, N(7)H), 
11.1 (bs. D20 ex. 1H, N(1)H). m/z = 284 (M+H)'.?unax (pH 7.3) 293nm and 246nm. 
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Appendix i. 
X-ray crystallography, dECGCQfiMeGAATTIGCGJ. 
Crystal data was collected by Dr. G. Leonard under the guidance of Dr. S. V. 
Phillips and Dr. W. Summers at the Department of Biophysics, Leeds University, 
using a Rigaku RU200 BB diffractometer, rotating anode and Nicolet-Siemens X100 
area detector system. 
A single crystal of dimensions 1.3 x 0.3 x 0.3 mm was mounted in a sealed glass 
capillary and X-ray data were collected at 277 0K on a Rigaku RU200 HB 
diffractometer equipped with a rotating anode X-ray generator and a Nicolet-
Siemens X100 area detector system. Data were processed using the XDS software 
package (Kabsch 1988). A total of 8543 reflections were merged to give 4481 
unique reflections (R merge = 0.03), representing 88% of the total data to a 
resolution of 2.0 A. A second data set was collected on a crystal of similar 
dimensions using a conventional Stoe-Siemens AED2 four circle diffractometer. The 
resultant 3735 reflections were corrected for absorption, decomposition, Lorenz and 
polarisation effects and merged (& merge =0.06) to yield 1953 unique reflections to 
2.5 A. The two data sets were scaled and merged (& merge = 0.03), to give a total of 
4557 unique reflections, 91% of the total data to 2.OA. The starting model for the 
refinement was obtained from the co-ordinates of the quasi-isomorphous 
d[CGCGAATTCGCG] 2 (Wing 1980) after idealising the geometry to allow for the 
slightly different unit cell (a = 25.44A, b = 40.70A, c = 65.99A, a = 0 = Y = 900, 
space group P2 1 21 2 1 ). The initial stepwise rigid body refinement, using a modified 
version of SHELX (Sheldrick 1976) on all data from 10.0 A to 2.5 A, converged at 
= 0.36. Subsequent Konnert-Hendrickson refinement (Hendrickson 1981) to 2.0 A, 
using NUCLSQ (16), including all reflections with F> 2Y(F) and omitting the base 
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pairs 0(4) - C(21) and C(9) - 0(16) from the structure factor calculations converged 
at K = 0.44. Examination of difference Fourier and 2F0 - F maps on an Evans and 
Sutherland PS300 system using FRODO (Jones 1978) clearly indicated that the 
mispairs had Watson / Crick geometry. The bases in positions 4 - 21 and 9 - 16 were 
then included as dG : T base pairs to avoid biasing the position of the methyl groups 
of the 06MedG bases and refinement was carried out using all data with F> 3(Y(F) 
in the range 7.0 A to 2.0 A. Positional and thermal parameters were included in the 
refinement which converged at ,& = 0.190 with the inclusion of 69 solvent molecules, 
all of which displayed good spherical density and hydrogen bonding geometry. The 
resultant F, - F difference maps showed substantial density in the plane of the 
mispairs, in a position expected for the proximal methyl group of 06MedG. Further 
refinement with the inclusion of the 06MedG base at positions 4 and 16 of the 
duplex converged to give K = 0.185 for 3118 reflections in the range 7.0 A to 2.0 A. 
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ABSTRACT 	The self-complementary dodecanucleotide 
d[CGC(m6 )AATTIGCG]2 (where M6  is 06-methylgua-
nine), which contains two m6GT base pairs, has been analyzed 
by x-ray diffraction methods and the structure has been refined 
to a residual error of R = 0.185 at 2.0-A resolution. The m 6G'T 
mispair closely resembles a Watson-Crick base pair and there 
are very few structural differences between the m6GT duplex 
and the native analogue. The similarity between the m6GT 
base pair and a normal GC base pair explains the failure of 
mismatch repair enzymes to recognize and remove this muta-
genic lesion. A series of ultraviolet melting studies over a wide 
pH range on a related dodecamer indicate that the m 6G-C 
mispair can exist in two conformations; one is a wobble pair 
and the other is a protonated Watson-Crick pair. The former, 
which predominates at physiological p11, will be removed by 
normal proofreading and repair enzymes, whereas the latter is 
likely to escape detection. Hence, the occasional occurrence of 
the protonated m6GC base pair may explain why the presence 
of m6G in genomic DNA does not always give rise to a mutation. 
The initial stages of chemical carcinogenesis frequently in-
volve the interaction of genotoxic agents with DNA to produce 
covalent modifications in the form of DNA adducts (1-3). An 
important example of this is the alkylation of the O' position 
of guanine residues in DNA resulting from exposure to meth-
ylating agents such as N-methyl-N'-nitro-N-nitrosoguanidiñe 
(4) and methyl methanesulfonate and N-methyl-N-nitrosourea 
(5). The presence of 0 6-methylguanine (m'G) constitutes a 
mutagenic lesion that is known to specifically induce GC to 
AT transition mutations (6) and it has been established that 
protooncogenes can be converted to oncogenes by such a 
process (7). Hence, the formation of the m 6GT base pair 
during replication can give rise to a carcinogenic lesion (8, 9). 
In recent years, the biochemical processes involved in chem-
ically induced carcinogenesis have been studied in consider-
able depth. However, to understand further the mechanisms of 
mutagenesis, it is necessary to analyze precisely the molecular 
details of the lesions produced when genotoxic agents interact 
with DNA. With this overall objective in mind, we have 
determined the structure of such a lesion, the m 6 &T base pair 
in a B-DNA duplex. 
MATERIALS AND METHODS 
All oligonucleotides were synthesized by the solid-phase 
method on an ABI model 380B DNA synthesizer using 
cyanoethyl phosphorámidite monomers. For those contain-
ing m6G, the following protocol was observed: The 5'-
dimethoxytrityl-N2-isobutyryl-06-methyldeoxyguanosine 3'-
cyanoethyl phosphoramidite monomer was utilized to intro-
duce 06-methyldeoxyguanosine and the fully assembled 
oligonucleotide was cleaved from the solid support and 
The publication Costs of this article were defrayed in part by page charge 
payment. This article must therefore be hereby marked "advertisement" 
in accordance with 18 U.S.C. §1734 solely to indicate this fact. 
deprotected in a 5% solution of 1,8-diazabicyclo[5.4.0]undec-
7-ene (DBU) in anhydrous methanol for 2 weeks at ambient 
temperature in an atmosphere of nitrogen (10). At no time 
was the oligonucleotide exposed to ammonia, as this can lead 
to the slow conversion of m6G to 2,6-diaminopurine (11). 
DBU was removed with Dowex-50 cation-exchange resin 
(Na form) and purification was accomplished by reversed-
phase HPLC (octyl), eluting with a linear gradient of aceto-
nitrile in 0.1 M ammonium acetate (0%-20%, 30 mm) to give 
a major and a minor -product in approximate ratios of 9:1. 
These were easily separated due to the much greater reten-
tion time of the latter. A sample of each was digested to the 
free nucleosides with snake venom phosphodiesterase and 
alkaline phosphatase and the base composition was analyzed 
by reversed-phase HPLC (10). In all cases, this confirmed 
that the oligonucleotide containing 0 6-methyldeoxyguano-
sine was the major product. The minor product was found to 
contain N2-isobutyryl-06-methylguanine, and it could be 
converted to the desired product by further treatment with 
DBU in methanol. Before carrying out pH-dependent ultra-
violet melting studies, the stability of m 6G at low pH was 
determined in the following way: The oligonucleotide 
d[CGC(jD60AATTCGCTJ was dissolved in 0.1M sodium 
phosphate (pH 5.0) and, after 2 weeks, reversed-phase HPLC 
analysis showed that there was no significant degradation. 
Mixed injections with the native sequence d(CGCjAAT-
TCGCG), which elutes much earlier on reversed-phase 
HPLC, further confirmed that the m 6G-containing oligonu-
cleotide had not undergone demethylation. 
The self-complementary dodecamer d(CGCjn 6 
AATtjGCG)2 crystallized isomorphously with the native do-
decamer (12). Crystals were grown at 277 K and pH 6.3 from 
25-pJ drops containing 1.0mM oligonucleotide, 33 MM MgCl 2 , 
16.7% (vol/vol) hexylene glycol, 1.25 mM spermine, and 5 mM 
sodium cacodylate. A single crystal of dimensions 1.3 x 0.3 X 
0.3 mm was mounted in a sealed glass capillary and x-ray - data 
were collected at 277 K on a Rigaku RU200 HB diffractometer 
equipped with a rotating anode x-ray generator and a Nicolet-
Siemens X100 area detector system. Data were processed using 
the XDS software package (13). A total of 8543 reflections were 
merged to give 4481 unique reflections (R merge = 0.03), 
representing 88% of the total data to a resolution of 2.0 A. A 
second data set was collected on a crystal of similar dimensions 
using a conventional Stoe-Siemens AED2 four circle diffrac-
tometer. The resultant 3735 reflections were corrected for 
absorption, decomposition, Lorentz and polarization effects 
and merged (R merge = 0.06) to yield 1953 unique reflections to 
2.5 A. The two data sets were scaled and merged (R merge = 
0.03) to give a total of 4557 unique reflections, 91% of the total 
data to 2.0 A. The starting model for the refinement was 
Abbreviation: m6G, 06-methylguanine. 
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9573 
9574 	Biochemistry: Leonard et al. 
obtained from the coordinates of the quasiisomorphous d(CGC-
GAATTCGCG), (12) after idealizing the geometry to 
allow for the slightly different unit cell (a = 25.44 A; b = 40.70 
A; c = 65.99 A. a = P = y = 900; space group P2 12 1 2 1). The 
initial stepwise rigid body refinement, using a modified 
version of SHELX (14) on all data from 10.0 A to 2.5 A, 
converged at R = 0.36. Subsequent Konnert-Hendrickson 
refinement (15) to 2.0 A. using NUCLSQ (16), including all 
reflections with F > 2o(F) and omitting the base pairs 
G(4)-C(21) and C(9)-G(16) from the structure factor calcu-
lations converged at R = 0.44. Examination of difference 
Fourier and 2F0 - F maps on an Evans and Sutherland 
PS300 system using FR000 (17) clearly indicated that the 
mispairs had Watson-Crick geometry. The bases in positions 
4-21 and 9-16 were then included as GT base pairs to avoid 
biasing the position of the methyl groups of the m 6G bases and 
refinement was carried out using all data with F> 3o(F) in 
the range 7.0 A to 2.0 A. Positional and thermal parameters 
were included in the refinement that converged at R = 0.190 
with the inclusion of 69 solvent molecules, all of which 
displayed good spherical density and hydrogen-bonding ge-
ometry. The resultant F. - Fc difference maps showed 
substantial density in the plane of the mispairs, in a position 
expected for the proximal methyl group of m 6G. Further 
refinement with the inclusion of the m 6G base at positions 4 
and 16 of the duplex converged to Rive R = 0.185 for 3118 
reflections in the range 7.0 A to 2.0 A. 
RESULTS AND DISCUSSION 
The x-ray structure analysis of the self-complementary do-
decanucleotide d[CGC(n 6 )AATfIGCG]2 shows that in 
overall shape the m 6GT mispair is remarkably similar to a 
Watson-Crick base pair. The bases are directly opposite each 
other, the glycosyl linkages are related by a pseudodyad, and 
in the minor groove the base pair is indistinguishable from a 
&C base pair. Overall, there are very few structural differ-
ences between the m 6&T duplex and the well-studied native 
GC duplex, d(CGCAATTGCG)2 (12). The helical param-
eters, torsion angles, and hydration pattern are almost iden-
tical and the presence of the mutagenic base pair does not 
distort the sugar-phosphate backbone. Despite these consid-
erable similarities, ultraviolet melting studies indicate that 
the m6GT duplex is much less stable than the native GC 
duplex (AG* = 46.8 kJ/mol) (Table 1). Hence, the m 6GT 
base pair has a powerful destabilizing effect in B-DNA. 
The two m6GT base pairs in the dodecamer duplex are 
essentially identical and the 2F, - Fc map of the m6G(9)T 
(16) pair is shown in Fig. la. There are three close contacts 
between the m6G and T bases; one of 2.9 A from purine-06 
to pyrimidine-04, a second of 2.9 A from purine-N 1 to 
pyrimidine-N 3 , and a third of 2.8 A between purine-N 2 and 
pyrimidine-02 . At this resolution, we cannot observe hydro-
gen atoms and the most likely base pair is shown in Fig. 2, 
with each base as its most common tautomer. There is 
unlikely to be a hydrogen bond between purine-0 6 and 
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pyrimidine-04 , as neither has an attached hydrogen and 
neither functional group is sufficiently basic to be protonated 
at pH 6.3. In addition, there is -no evidence in the pH-
dependent ultraviolet melting 5iofif f43e duplex (Fig. 3a) 
for a protonated base pair. Hence. 'formation of the double 
strand from the fully hydrated single strands will lead to the. 
loss of a hydrogen bond between each of these oxygen atoms 
and neighboring solvent molecules. As these are not replaced 
by interbase hydrogen bonds, the effect will be to destabilize 
the duplex. The interaction between purine-0 6 and pyrimi-
dine-04 will be destabilizing for the additional reason that the 
two electronegative oxygen atoms are forced together by the 
two adjacent strong hydrogen bonds in the base pair (20), one 
from pyrimidine-N 3 to purine-N 1 and a second from pu-
rime-N 2 to pyrimidine-0 2. It is possible to postulate other 
forms of the m6 &T base pair by invoking minor tautomers but 
there is no direct experimental evidence for their existence. 
The base pair in Fig. 2 has two hydrogen bonds that are 
adjacent to each other and the resultant cooperativity allows 
the formation of a stable base pair. The m 6GT base pairing 
found in the present x-ray structure is identical to that 
postulated from molecular orbital and molecular mechanical 
calculations and from an NMR study of a mixture of ribo-
nucleosides of m6G and thymine in chloroform solution (21). 
However, it differs in important details from that proposed in 
an oligonucleotide NMR study, although interpretation of the 
spectra was limited by the lack of direct information on the 
relative orientation of the two bases (22). 
The most striking differences between the m 6GT mispair 
and a GC base pair are in the major groove, due to the 
presence of the methyl group attachdto the purine-0 6 atom, 
located proximal to the N 7 atom in the plane -of the purine ring 
(Fig. lb). This will give rise to steric repulsion between the 
guanine base and the attached methyl group. Although the 
distal conformation is preferred in the free nucleoside (23, 
24), it is likely to be very unstable in the m 6GT base pair (25) 
as it will prevent the formation of interbase hydrogen bonds. 
In the proximal orientation, the methyl group presents a 
steric barrier to any regulatory or repair enzyme that might 
otherwise interact with the guanine-0 6 or -N7 atom. The 
appearance of the m 6GT base pair in the major groove is 
different from that of a Watson-Crick AT or GC base pair 
in two additional details: (i) there are two methyl groups, one 
attached to each base, and (ii) there is no heteroatom with a 
capacity to donate hydrogen bonds. 
When a guanine base in genomic DNA is converted to M6  
by a chemical mutagen, the modified base normally codes for 
thyrnine instead of cytosine (26), resulting in an in vivo 
mutation frequency of between 15% (27) and 75% (28). The 
in vitro misinsertion frequency is >95% (29) and the only 
efficient form of repair involves demethylation of the 06  atom 
of guanine by the enzyme m6G methyltransferase to regen-
erate guanine (30, 31). Thus, the m 6GT base pair is recog-
nized as being more similar to a Watson-Crick base pair than 
is the m6GC base pair. The reasons for this are unlikely to be 
thermodynamic in origin (18, 19), as ultraviolet melting 
Table 1. Thermodynamic parameters for d(CGCXAA1'TYGCO) 2 duplexes at pH 7.0 in 1.0 M 
NaCl/lO mM sodium phosphate/1 mM EDTA 
Base pair Ji°, kimol' L.S°, Jmol'K' AG*, kJmoM tm, K 
GC -430.1 -1164 -83.2 344.6 
AT -399.0 -1085 -75.7 341.6 
-331.7 -937.6 -52.3 324.4 
m60C -213.7 -592.3 -37.2 317.1 
m6GT -208.4 -577.3 -36.4 315.2 
Thermodynamic parameters were determined from the concentration dependence of ultraviolet 
melting by standard methods (18, 19). Each point on the curve was measured in triplicate. tm , melting 
temperature at 40 1LM oligonucleotide; X, any nucleotide; Y, any nucleotide except that represented 
by X. 
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removed from the structure factor calculations. The methyl group is located in the proximal conformation in the plane of the purine ring. 
studies show that the duplex containing the m 6GT base pair 
is slightly less stable than the corresponding m 6G'C duplex at 
neutral p1-I (AG" = 0.8 kJ/mol) (Table 1). Moreover, the 
m6GT duplex is less stable than the duplex containing the G'T 
wobble base pair mismatch, which is rarely incorporat-





FIG. 2. m'GT base pair with each base as its major tautomer 
The incorporation of the m 6G•T base pair in preference to 
the m6G'C base pair in genomic DNA can be rationalized in 
structural terms. The similarity in shape between the m 6G'T 
mispair and a Watson—Crick base pair, particularly in the 
minor groove is striking, whereas the m 6G'C base pair has 
been postulated on the basis of theoretical and NMR studies 
to be a reverse wobble base pair as in Fig. 4a (32, 25). This 
would, by analogy with mismatch base pairs, be removed by 
proofreading. Thus the enzymes in the cell nucleus respon-
sible for DNA synthesis and repair discriminate in favor of 
the mutagenic lesion. We have studied the stability profile of 
the DNA duplex containing the m 6GC base pair over a wide 
pH range (Fig. 3b) and we have observed that the melting 
temperature falls slightly from pH 8.5 to pH 6.5, as would be 
expected for the unprotonated wobble base pair 4a. At lower 
pH however, there is a clear indication of duplex stabiliza-
tion, probably due to protonation of cytosine-N 3 of the 








4.0 	 5.0 	 6.0 	 7.0 	 8.0 
pH 
FIG. 3. pH-dependence of ultraviolet melting for 
d(CGCm6GAA1TFGCG) (squares), d(CGCm 6GAATFCGCG) (dia-
monds), and d(CGCGAATTCGCG) control (circles). Ultraviolet 
melting curves were measured over a wide pH range at 264 nm in 
aqueous 0.1 M sodium phosphate/1 mM EDTA. Each point on the 
curve was measured in triplicate. 
mispair, which would - lead to the formation of a Watson-Crick-
like base pair, a resonance form of which is shown in Fig. 4b. 
Thus, the m6GC base pair displays conformational flexibility. 
The protonated base pair 4b, which is probably present to 
some extent at neutral pH, would be expected on structural 
grounds to be incorporated during replication. Such a base pair 
has been identified in an NMR study of a mixture of the 
nucleosides in nonaqueous solvents (21) and in a preliminary 
report of an x-ray structure of a Z-DNA duplex (33). The 
occasional occurrence of 4b might explain why the presence of 
m6G in genomic DNA does not always lead to a mutation. 
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FIG. 4. (a) m6G'C wobble base pair. (b) Protonated m6 GC base 
pair. 
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